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Abstract 
The value of screening for cervical cancer has been proven; as such screening 
has resulted in a decrease in incidence and mortality of cervical cancer by over 80% in 
developed countries1.  Yet despite a screening infrastructure, cervical cancer is the most 
common female malignancy in South Africa2, affecting 1 in ever 41 women.3  It is 
estimated that more than 3,400 South African women die of cervical cancer every year4.  
In the year 2000, the South African Department of Health initiated its National Guideline 
on Cervical Cancer Screening Program.  The program, based on World Health 
Organization (WHO) guidelines for low-resource settings, calls for South African women 
to receive 3 smears per lifetime with a 10 year interval between each smear, commencing 
at no earlier than age 30.  The ultimate goal is to screen 70% of targeted women, 
nationally, within 10 years of initiating the program in order to reduce the incidence, 
morbidity, mortality and cost of cervical cancer.5  
In this study, I evaluate the implementation challenges and content suitability of 
the 2000 National Guideline on Cervical Cancer Program in KwaZulu-Natal (KZN) by 
triangulating the data I have collected from interviews with relevant stakeholders in the 
cervical cancer field,  pertinent secondary sources on the topic and my general 
observations living and studying in KZN from the period of 8 September 2006 to 7 
December 2006.  
The evidence I detail suggests that the current National Guideline on Cervical 
Screening Program does not appear to be comprehensively implemented in KZN and may 
not be suitable within the context of the HIV/AIDS epidemic.  In this piece, I discuss 
possible reasons for this alleged failure of implementation, citing evidence that 1) there 
are inadequate resources in the public sector, that 2) health care workers are 
overstrained causing i. pap smears to fall low on the list of health priorities, ii. provider 
attitudes that discourage clinic attendance and iii. a possible information-dissemination 
failure from healthcare provider to patient and that 3)  there is inadequate publicity of 
the cervical screening program to the public at large.  I then discuss data that suggests 
that even if implemented, the cervical screening policy may not be suitable in KwaZulu-
Natal because such a substantial portion of the young female population is infected with 
HIV. Evidence suggests that HIV decreases the age at which women have cervical 
cancer, decreases the interval of time from dysplasia to cancer and increases the 
likelihood of false-negative results of pap smears.  As such, HIV-positive women should 
be getting pap smears at young ages and at frequent intervals. Finally, in an epilogue, I 
discuss exciting new developments in the cervical cancer field. 
 
                                                 
1 Sankaranarayanan, R., Budukh, AM. & Rajkumar, R. Effective screening programmes for cervical cancer 
in low-and middle-income developing countries. Bulletin of the World Health Organization, 2001.  
2 Wellensiek, N., Moodley, M. Moodley, J.&  Nkwanayana, N. Knowledge of cervical cancer screening 
and use of cervical screening facilities among women from various socioeconomic backgrounds in Durban, 
Kwazulu- Natal, South Africa. International Journal of Gynecological Cancer 2002, 12, 376-382. 
3 National Guideline on Cervical Cancer Screening Programme. Republic of South Africa Department of 
Health, 2000. 
4 CANSA, Cancer Association of South Africa, More services needed to fight cervical cancer 
(www.givengain.com), 29/10/2006. 
5 National Guideline on Cervical Cancer Screening Programme, 2000.  
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Introduction 
 
     
Cervical Cancer and HPV infection 
 
Cervical Cancer is the second most common cancer in women worldwide, with 
about 500,000 new cases and 250,000 deaths every year. Unlike most other forms of 
cancer, cancer of the cervix is preventable, using relatively inexpensive screening to 
detect and treat abnormal cervical tissue before it progresses into invasive cancer.6  The 
earlier the detection of abnormal cell tissue (known as dysplasia), the better the chances a 
patient has of complete recovery7.  
Virtually all cervical cancer cases (99%) are linked to genital infection with 
Human Papillomavirus (HPV), which is the most common viral infection of the 
reproductive tract.8 The rate of transmission of HPV is several orders of magnitude 
greater than other STIs and transmission does not require full penetrative intercourse or 
many partners.  Most HPV infections have no signs and no symptoms and most infected 
people are unaware that they are infected.9 There are 40 different genotypes of HPV that 
can infect the genital area of both men and women.  HPV 16 and 18 are considered high-
risk genotypes and are responsible for the majority of HPV-related cancers of the cervix, 
                                                 
6 Preparing For the Introduction of HPV Vaccines: Policy and Programme Guidance for Countries . 
WHO/UNFPA.  Based on UNFPA/WHO Technical Consultation of HPV Vaccines and Sexual and 
Reproductive Health Programs held in March 2006 in Montreux, Switzerland.  
7 CANSA, 2006.  
8 Preparing For the Introduction of HPV Vaccines, March 2006.  
9  Preparing For the Introduction of HPV Vaccines, March 2006.  
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vulva, vagina, anus and penis worldwide10.  HPV genotypes 6 and 11 cause a substantial 
proportion of low grade cervical dysplasia detected in screening.11
In most cases12, cervical cancer develops slowly.  HPV infects the cells of the 
cervix and causes cell dysplasia (also called cervical intraepithelial neoplasia or CIN). 
Cancer of the cervix develops from these dysplatic precursor lesions, progressing steadily 
from mild (CINI) to moderate (CINII) to severe (CINIII) dysplasia,13 then to carcinoma 
in situ14 and finally to cancer15.  The direct precursor of cervical cancer is high- grade 
dysplasia which in 1/3 of cases progresses to cervical cancer usually over a period of 10-
15 years.  Around 90% of low-grade dysplasias regress spontaneously. Besides HPV 
other risk factors for cervical cancer include high-risk sexual activity patterns, oral 
contraceptive use and smoking. 16
Women generally are infected with HPV in their teens, 20s, or 30s.  The disease, 
if it persists, can take up to 20 years after initial HPV infection to develop. On the whole, 
cervical cancer peaks at about age 50 and severe dysplasia risk peaks at about age 35.17
Once cervical cancer develops, it starts at an in situ stage than can be treated, but 
then progresses to invasive disease that is always fatal where surgery and radiation 
therapy are unavailable18.  Symptoms of late stage cervical cancer include bleeding 
                                                 
10 Preparing For the Introduction of HPV Vaccines, March 2006.  
11 Preparing For the Introduction of HPV Vaccines, March 2006. 
12 Dysplasia progresses differently in patients that are HIV positive.  Such differences will be discussed 
extensively below. It is vital to note that the cervical cancer discussion in this section is describing the 
disease as an overview and assumes HIV negative status.  
13 A new classification has recently been introduced whereby the precursors are named squamous intra-
epithelial lesions (SIL) which are divided into low-grade SIL (similar to CIN1) and high grade SIL (for 
CIN11 and CIN111).  Both classifications are used today.  
14 In situ is latin for “in its original place.” 
15 Sankaranarayanan et al., 2001.  
16 Cervical Cancer Prevention.  Reproductive Health Outlook. (http://www.rho.org). 18/10/2006. 
17 Cervical Cancer Prevention. RHO, 18/10/2006. 
18 Cervical Cancer Prevention. RHO, 18/10/2006. 
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between monthly periods, unusually heavy periods, pain during intercourse, bleeding 
after intercourse or after pelvic exam and bleeding after menopause19.  
To detect cellular dyplasia, a Papanicolaou (Pap) smear is performed20.  A Pap 
smear is a cytological test designed to detect abnormal cervical cells. The procedure 
involves scraping cells from the cervix and then smearing and fixing them on a glass 
slide. The slides are sent to a cytology laboratory and evaluated by a trained cytologist or 
cytotechnician who determines the cell classification.21 If abnormalities are found, a 
coloposcopy is performed to determine the cause of the abnormalities.  A coloposcopy is 
a visual examination of the cervix and is a relatively simple and painless procedure that 
lasts approximately 10 minutes.  
 
Cervical Cancer in the Developing World  
 
While frequently repeated cytology screening has led to an 80% decline in 
cervical cancer mortality in the developed world, cervical cancer remains an important 
public health problem among adult women in developing countries.  Approximately 
190,000 women in developing countries die from cervical cancer every year.  It has been 
estimated that only 5% of women in developing countries have been screened for cervical 
                                                 
19CANSA, 29/10/2006  
20 There are other ways in which cellular dysplasia can be detected.  One relatively novel way is the use of 
acetic acid to detect abnormalities.  This may be extremely beneficial in low resource settings. Please see 
the Epilogue for a further discussion on the use of acetic acid in cervical cancer screening.   
21 Cervical Cancer Prevention, Fact Sheet. Alliance for Cervical Cancer Prevention. (www.path.org), 
22/11/06. 
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dysplasia in the past 5 years compared with 50% from developed countries22. 
Furthermore, developing countries have access to only 5% of global cancer resources23. 
It is generally undisputed that cervical screening fulfills the criteria of an effective 
screening program, which includes cost effectiveness, reduction of incidence of a disease 
and reduction of morbidity and mortality from a disease24.  Yet due to more limited 
health care resources, developing countries often cannot afford the model of frequently 
repeated screening of a wide age range of women that are used in developed countries.  
In such resource limited settings, the World Health Organization (WHO) supports the 
concept of reducing the number of smears per women per lifetime in favor of more 
women in the population having fewer smears.  According to the WHO, it is more 
realistic and effective to target a national screening program to high risk women once or 
twice in their lifetime using a highly sensitive test, with an emphasis on high coverage of 
the target population.25   
 
South Africa and Cervical Cancer  
 
In South Africa, despite a screening infrastructure, cervical cancer is the most 
common female malignancy affecting 1 in every 41 women26. The majority of South 
African women have never been screened for cervical cancer and only present at facilities 
with advanced staged disease27.  Cervical cancer accounts for 17% of all cancers in South 
                                                 
22 Cervical Cancer Prevention. RHO, 18/10/2006. 
23 Smit, J., Beksinska, M., Ramkissoon, A.,  Kunenei B., & Penn-Kekanaii, L. Chapter 5: Reproductive 
Health. South Africa Health Report 2004.  
24 Wellensiek et al., 2002.  
25 Sankaranarayanan et al., 2001. 
26 National Guideline on Cervical Cancer Screening Programme., 2000.  
27 CANSA, 29/10/2006. 
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Africa and has an incidence of approximately 30 in 100,000 women28.  It is estimated 
that more than 3,400 South Africans die every year form cervical cancer and it is the 
leading cause of cancer deaths in South African women.29
Like many other health-related services, access to cervical screening and rates of 
cervical cancer incidence in South Africa are divided along racial lines.  A 2004 study 
found that over 90% of white women and only 5% of African women had accessed 
cervical screening in the past 10 years30. Furthermore, it is estimated that 1 in 25 African 
women will develop cervical cancer in her lifetime, whereas 1 in 34 colored women and 
1 in 81 white and Asian women will develop the disease31.32   
Over South Africa’s history, cervical cancer policies have evolved with time.  In 
the 1970s the Department of Health advocated that pap smears be performed if the cervix 
of a patient ‘looked’ abnormal.  This policy was quickly abandoned because by the time a 
clinician would detect an abnormality in the cervix, the cancer was already advanced. In 
the early 1980s, the availability of pap smears decreased because cervical cancer deaths 
were decreed to be less serious than other health challenges.  In 1989, the policy to screen 
women once in their lives at age 40 was initiated, but no coordinated mechanism to 
implement this policy was ever developed.33
                                                 
28 Wellensiek et al, 2002. 
29 CANSA, 29/10/2006.  
30 Smit et al., 2004.  
31 CANSA, 29/10/2006.  
32 On a national level, there is still no statistical data collected in South Africa on the number of women 
screened for cervical cancer, the percent of women detected with abnormal smears or the percent of women 
treated or referred for cervical cancer treatment. Smit et al., 2004.  
33 Cervical Cancer Prevention, RHO, 18/10/2006. 
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In the year 2000, the South African Department of Health initiated its National 
Guideline on Cervical Cancer Screening Program34, which has not changed to the present 
day.  The program is largely based on the International Agency for Research on Cancer 
(IARC)35 guidelines36.  The program states that South African woman will receive 3 Pap 
smears per lifetime with a 10 year interval between each smear, commencing at no earlier 
than age 30.  The ultimate goal is to screen at 70% of women, nationally, within this 
target age group within 10 years of initiating the program. Its objectives are to reduce the 
incidence of carcinoma of the cervix, primarily by detecting and treating the pre-invasive 
stage of the disease, to reduce the morbidity and mortality associated with cervical cancer 
and to ultimately reduce the excessive expenditure of scarce health funds currently spent 
on the treatment of invasive cancer of the cervix.  The National Guideline asserts that this 
policy reflects the best attempt to reduce the incidence and mortality of cervical cancer by 
more than 60 percent and is based on “the best available evidence in low-resource 
settings.” 37
This short study attempts to critically examine the current screening program as it 
approaches its seventh year of initiation.  The analysis relies on interviews conducted 
with a diverse group of relevant stakeholders throughout KwaZulu-Natal, several 
pertinent secondary sources and my experiences as a student studying and living in 
Durban.  Throughout this study, I will argue that the Department of Health’s 2000 
                                                 
34 Please see Appendix D for a full copy of the National Guideline on Cervical Cancer Screening 
Programme. 
35 The IARC is a department of the WHO.  
36 The South African Institute for Medical Research, Women’s Health Project, Cancer Association of South 
Africa, National Institute of Virology all helped develop the National Guideline.  
37 National Guideline on Cervical Cancer Screening Programme, 2000. 
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Cervical Cancer Screening Program seems to have largely failed in KZN38 because it 
appears not to be comprehensively implemented in the province and may be unsuitable 
within the context of the HIV/AIDS epidemic.  I will begin, in Part One, by describing 
the apparent inability to implement the screening policy into practice in KZN and provide 
some of the possible reasons behind this failure of implementation.  Then in Part Two, I 
will describe why, if implemented in its current form, the program would likely still be 
unsuccessful in achieving its goals because of a well-documented association between 
cervical cancer and HIV/AIDS.   
 
 
 
 
 
 
 
 
 
 
 
 
                                                 
38 Due to the fact that my observations and experiences were limited to KwaZulu-Natal, I cannot 
reasonably comment on whether or not the program could potentially be successful in other parts of South 
Africa or in other developing countries.  It is vital to note that many of my primary and secondary sources 
spoke of problems with the cervical cancer screening policy in South Africa as whole, and not just 
problems specific to KZN.  As the largest province in the country with 9 million inhabitants, and as an area 
disproportionately burdened with many of the countries worst public health problems, many challenges of 
policy implementation described as issues in the whole of South Africa are likely relevant to KZN.  
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Methodology 
 
All data, both primary and secondary used in this study was collected in 
KwaZulu-Natal, South Africa from the period of 8 September 2006 to 7 December 2006. 
The interviews with relevant stakeholders in the cervical cancer field were conducted in 
various sites in Durban, South Africa from the period of 13 November 2006 to 1 
December 2006. The data from each primary source used in this study was collected in a 
unique way, as each source is unique.  The context in which each piece of evidence was 
collected is an important factor in understanding that evidence.  The details behind the 
data of each primary source in the order I met with them are described below39.  
 
 
Ruby Makhathini- Ruby is a 62-year old Zulu woman who lives in a government subsidized home 
in Cato Manor, Durban, South Africa.  Ruby did not attend university, currently does not work and had 2 
children in her lifetime, but lives only with her grandson Bhuwa today.  All information I obtained from 
Ruby was through casual conversations throughout the time that I lived I her household between 9/9/06 to 
4/10/06,40 as well as a visit on her birthday on 02/11/06.  Ruby and I would talk about a myriad of topics 
while she cooked and cleaned or while we were watching TV.  All the data used in this study was obtained 
when Ruby and I were conversing alone.  
Manto Tshabalala-Msimang- Dr. Manto Tshabalala-Msimang is a South Africa’s Minister of 
Health.  On 6 October 2006 she spoke at a community event in Mpumalanga to commemorate the Breast, 
Cervical and Prostate Cancer Month.  I obtained the contents of her speech on the Department of Health 
website (www.doh.gov.za).   
Mark Colvin- Mark Colvin is an epidemiologist affiliated with the University of KwaZulu-Natal 
(UKZN).  The data I obtained from Mark Colvin was during his two power-point lectures to 17 American 
students from the School of International Training on Public Health and Epidemiology and on HIV and 
AIDS in South Africa on 19/09/2006 and 27/10/2006 respectively. 
Catherine Burns- Catherine Burns is historian at UKZN. The data I obtained from Catherine 
Burns was during her lecture to 17 American students from the School of International Training on the 
History of Health in South Africa on 26/09/2006.  
Sister Thandanani Simelani- Sister Simelani is a South African nurse. The data I obtained from 
Sister Simelani was when she came and lectured to the School for International Training students in the 
Community Center in Nyoni on 13/10/06 after a full days work in the clinic. Nyoni is a rural town about 90 
kilometers north of Durban. 
Dr. Duze- Dr. Duze is a South African doctor who grew up in a rural area. The data I obtained 
from Dr. Duze was when he came and lectured to 17 American students from the School of International 
                                                 
39 Please see the Limitations of the Study section for predisposed and researcher-influenced biases of each 
source. 
40 I lived with Ruby during the ‘homestay’ portion of the School for International Training (SIT) Study 
Abroad Program I attended in South Africa. It is important to note that I, as well as all other SIT students, 
was assigned to whom we would be living with in Cato Manor, and did not get to choose our home.  
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Training on 02/11/06 on his experiences as a doctor in a rural hospital.  The lecture took the form of a 
question-answer session in which students would ask Dr. Duze to discuss a particular topic. 
Dr. Amo Jordaan—Dr. Amo Jordaan is the Head of the Radiation Oncology Department at 
Addington Hospital.    I met with Dr. Jordaan in his office at the Oncology Clinic of Addington Hospital on 
15 November 2006.  At Addington, Dr. Jordaan sees women who have already been diagnosed with 
cervical cancer, and as such, has insight into the factors behind getting the disease.  I obtained data from 
Dr. Jordaan when sitting across from him at his desk.  
Addington Hospital- Addington Hospital is 524 bed, 2,200 staffed district and regional hospital in 
South Beach, Durban.  I arrived at the hospital in order to meet with Dr. Jordaan at around 12:00 on 15 
November 2006 and had to walk through several corridors in order to reach the Oncology Clinic where I 
was to interview Dr. Jordaan.  
Mags Beksinska- Mags Beksinska is Director of the Durban office of the Reproductive Health and 
HIV Research Unit (RHRU), whose main office is based at the University of Witwatersrand in 
Johannesburg. The RHRU is one of the foremost South African Institutions engaged primarily in research 
and training in the field of reproductive health. It is also affiliated with the WHO as a collaborating center. I 
interviewed Mags Beksinska in her office at the Durban RHRU headquarters in Westville.  Mags 
Beksinska does work in the Antiretroviral (ARV) rollout centers and has insight into cervical cancer 
screening in these clinics.   
Gender AIDS Forum (GAF)- The Gender AIDS Forum is a Durban- based South African activist 
NGO, committed to advocating the links between gender and HIV/AIDS. GAF researches many 
reproductive health issues including cervical cancer. I went to GAF on 20 November 2006 after  I met one 
of their researchers, Elizabeth Elston, who said they may have helpful data in their resource room as they 
have worked on cervical cancer screening in the past.  I spent the day researching documents written by 
GAF in their resource room with direction from Elizabeth Elston as of where to look.  
Charlie Roberts- Dr. Charlie Roberts is a General Practitioner at Entabeni Hospital. I interviewed 
Dr. Roberts over the phone on 21 November 2006 asking him questions about cervical cancer screening in 
the private sector and his general insight as a doctor about the challenges in the field at the present time.  
Paula Warren- Dr. Paula Warren is a 26- year old General Practitioner at Entabeni Hospital.  Dr. 
Warren spent her community service year41 in a rural clinic in Northern KwaZulu-Natal in 2005.  In this 
clinic, she was working with another community service year doctor and four nurses. I interviewed Dr. 
Warren at her medical practice at Entabeni Hospital.   
Entabeni Hospital- Entabeni is a private hospital in Durban, South Africa. It is a member of Life 
Healthcare, one of the largest private hospital groups in South Africa with 62 acute care facilities across the 
country. I went to Entabeni Hospital on 23 November, 2006 and waited briefly in waiting room of the 
Central Medical Suite before meeting with Dr. Warren.  
Joel Perry- Joel Perry is the Cancer Association of South Africa’s (CANSA) Director of Health 
Programs.  CANSA is an NGO who goal is to substantially reduce the impact of cancer by promoting 
health in all communities within South Africa, through advocacy and the sustainable facilitation of 
research, prevention, early detection and care.42 I spoke briefly with Joel Perry on the phone, but as he did 
not have the time to meet with me he asked me to e-mail him my questions.  He responded an hour later 
with detailed answers.  
Dr. G.- Dr. G is a black, male Gynecologist working at the Obstetrics and Gynecology 
Department of the Inkosi Albert Luthuli Hospital in Central Durban. I use “Dr. G.” in order to keep his 
identity hidden.  The data I obtained from Dr. G. was in the morning of 30 November 2006 when I 
observed him at work in a consultation room of the Obstetrics and Gynecology clinic at Inkosi Albert 
Luthuli Central Hospital.  In the time that I was in Dr. G’s consultation room he saw three patients.  The 
first patient who came in was menstruating, so she was given an appointment to come back the next week.  
The second patient to come in was referred to the wrong department by a doctor at King Edward VII 
Hospital and was thus not seen.  The third patient was a 26-year old Zulu woman who was HIV positive 
and was referred for treatment of high-grade cervical lesions from the Medical Research Council Clinical 
Trials.  All patients gave their consent that I could be sitting in on their consultation.  
                                                 
41 After finishing Medical School, South African’s must work one ‘community service’ year in the public 
sector before they can qualify as doctors.  
42 Found at www.givengain.com. 
 13
Dr. Z.- Dr. Z is a black, female Oncologist working at Obstetrics and Gynecology Department at 
Inkosi Albert Luthuli Hospital in Central Durban. I use “Dr. Z.” in order to keep her identity hidden.  The 
data I obtained from Dr. Z. was in the morning of 30 November 2006 when I observed her at work in a 
consultation room of the Obstetrics and Gynecology clinic at Albert Luthuli.  In the time that I was in Dr. 
Z’s consultation room she saw one patient, a white woman who had cancer in her right ovary and had 
recently undergone an operation.  The patient gave her consent that I could be sitting in on her consultation. 
Inkosi Albert Luthuli Central Hospital-  Inkosi Albert Luthuli is well-resourced  tertiary and 
quaternary hospital open to patients in Central Durban.  It is open for all people needing late-stage medical 
treatment from the whole of KwaZulu-Natal and parts of the Eastern Cape. After describing in detail the 
purpose of my study, I received permission from the head of the Obstetrics and Gynecology clinic to 
shadow doctors in the hospital on the morning of 30 November 2006.  I also received permission to use the 
name of the hospital in this study.  I sat first in the consultation room of Dr. Z around 10:00 with one 
patient and then moved to Dr. G’s consultation room for 2 hours during which he saw 3 patients.   
  Manivasan Moodley-  Dr. Manivasan Moodley is a doctor and researcher at Department of 
Obstetrics and Gynecology, Nelson R. Mandela School of Medicine.  Dr. Moodley is my advisor for this 
project.  We corresponded through telephone and e-mail before we met on 1 December 2006.  I interviewed 
and discussed cervical cancer screening issues—particularly the link between HIV infection and cervical 
cancer—with Dr. Moodley across from his desk at his office at the Nelson R. Mandela School of Medicine.  
 
I also rely significantly on the secondary sources that inform this paper.  My secondary 
sources are limited to nineteen articles and documents obtained through search engines 
on the World Wide Web and through research in the GAF resource room.  In addition, 
several pertinent documents were given to me when I met with interviewees, who thought 
that certain papers would be applicable to my study.  For a list of each secondary source 
and a brief note on how it is relevant to the study, please see the Literature Review.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 14
Literature Review: 
 
 
Anderson J.., Shah, K., Paramsothy, P., Heilis, C., Jamieson, D. & Duen, A. Predictive 
value of pap smear screening in HIV infected and high risk HIV uninfected women. 14th 
International AIDS Conference, Barcelona, Spain. July 7-12, 2002. This article provides 
evidence that HIV positive women with CD4 less than 500/mm3 are more likely to 
have false negative pap smears and screening at shorter intervals may be 
warranted.  
 
Barnabas L., Madlala N., Magwaza T., Maphumulo T., Mcanyana N, Mlambo R, 
Mpungose, G., Ngidi C., Tallis V. & Tolofi, R..“Things are so wrong out there”: The 
experiences of women living with HIV & AIDS in accessing sexual and reproductive 
health & rights in KwaZulu Natal, South Africa: A study with women living with HIV and 
AIDS.  24, January 2006. This article highlights women’s difficulties in accessing their 
reproductive and sexual rights within the public health sector.  The comments and 
experiences of women throughout KwaZulu-Natal are used throughout this study.  
 
CANSA, Cancer Association of South Africa, More services needed to fight cervical 
cancer (www.givengain.com), 29/10/2006. This website provides facts and figures 
specific to South Africa on cervical cancer.  
 
Cervical Cancer Prevention, Fact Sheet. Alliance for Cervical Cancer Prevention. 
(www.path.org), 22/11/06. This website provided information about the cytology 
laboratory where pap smear results are analyzed.  
 
Cervical Cancer Prevention.  Reproductive Health Outlook. (http://www.rho.org). 
18/10/2006. This paper is used throughout the piece.  It provides facts and figures 
about cervical cancer both in general and specific to South Africa.  It is used to 
provide a history of cervical cancer screening within the South African context. The 
paper is also cited in the discussion of the natural progression of cervical cancer and 
provides evidence of the link between HIV and cervical cancer.  
 
Clark B. & Chetty, R. Postmodern cancer: the role of human immunodeficiency virus in 
uterine cervical cancer. Molecular Pathology, 2002 Feb;55(1):19-24. This paper found 
that HIV causes more rapid progression to high grade and invasive cervical cancer 
lesions.  
 
Cooper, D., Marroni, C., Orner, P., Moodley, J., Harries, J., Cullingwath L. & Hoffman, 
M. Ten Years of Reproductive Health Policy and Status. Reproductive Health Matters 
2002, 12 (24): 10-85.  This article documents the changes in reproductive health 
policy since the advent of democracy in South Africa.  It briefly discusses cervical 
cancer as one of the key areas of sexual and reproductive health. It is cited in the 
concluding discussion of this study as it provides evidence of the progressive 
reproductive health policies in South Africa.  
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Findings and Analysis  
PART ONE: A Failure of Implementation 
 
“Readiness for implementation is still a challenge for the health services in the public 
sector.  As a result cervical screening is a far cry from what is proposed”-Joel Perry, 
CANSA Director of Health Programs43  
 
As stated above, the ultimate goal of the 2000 Cervical Cancer Screening program 
is to screen 70% of women, nationally, in the target age group of 30-50 years within 10 
years of initiating the program.  Yet based on the data obtained throughout my study it 
seems apparent that, as its approaching its seventh year of induction, the South African 
cervical screening program is not being comprehensively implemented into practice. 
 The evidence that I found of a widespread belief in the failure of the cervical 
screening policy’s implementation was extensive.  When meeting with Dr. Amo Jordaan, 
Head of the Radiation Oncology Department at Addington Hospital, he stressed to me 
that “the majority of South Africans are not screened today, especially not the ones in 
need44.” Dr. Paula Warren, a General Practitioner who spent her community service year 
working in a rural clinic in KZN,  put it even more bluntly, “the 30-50 policy is not 
enforced; not at all. Most of the women I saw [in the clinic] never had a pap smear in 
their lives45.” In a 2004 study conducted throughout KZN only 31% of public sector 
facilities were found to have cervical screening services, lower than the national average 
                                                 
43 Joel Perry. Cancer Association of South Africa (CANSA) Director of Health Programs. Interview. 
27/11/06. All phrases found in quotation marks are direct quotations.  
44 Dr. Amo Jordaan.  Head of Oncology, Addington Hospital. Interview, 15/11/06.  
45 Emphasis added.  Dr. Paula Warren, General Practioner, Entabeni Hospital. Interview, 23/11/06. 
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of 49.6%. And the 2004 South African Health Review (SAHR) stated that “although 
screening has been provided through the South African public sector health facilities for 
many years, there has been minimal impact on cervical cancer morbidity and mortality 
because of limited screening of the population at risk46.”   
While speaking to relevant stakeholders and reading pertinent documents throughout 
my study, I have found evidence that the failure of implementation of the cervical cancer 
screening policy appears to be a result of many factors.  These include 1) resource 
shortages in public sector facilities, 2) the consequences of a system with overstrained 
health care providers and 3) a lack of public education on the value and purpose of 
cervical screening.47
 
1. Inadequate Resources 
 
“Even if you perform a pap smear, how do you manage a patient with no resources?”- 
Dr. Charlie Roberts, General Practitioner, Entabeni Hospital 48
 
To have an effective cervical cancer screening program, you need the appropriate 
screening resources.  The 2004 SAHR asserted that “effective implementation [of the 
2000 Cervical Screening Program] has been hampered by general weakness in the public 
                                                 
46 Smit et al., 2004.  
47 There are other factors that may contribute to the cervical screening uptake failure such as a patients own 
personal or cultural beliefs that prevent her from coming into the clinic, ignorance of the issues among 
healthcare providers, a lack of public will to get screened etc. Due to the limited nature of this study I will 
only go into the factors listed.  
48 Dr. Charlie Roberts, General Practioner, Entabeni Hospital. Interview, 21/11/06.  
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health system stemming from lack of financial and human resources.”  Throughout my 
work, I have found substantiation to the resource-deficiency claim. 
 My interview with Dr. Warren shed light on one of the most striking indications 
of the scarcity of resources in a clinic.  During Dr. Warren’s year of community 
service49, she worked in a rural clinic in northern KZN for 12 months.  I asked her about 
how often and to whom the Sisters50 would give pap smears to in the clinic. Dr. Warren 
explained: 
 
While we would try our best it was just impossible. First of all, the lab cannot possibly cope 
with the number of pap smears you would need. And even if it did, it would still be 
impossible.  The best we could do would be 3 paps in a day from an instrumental point of 
view, we only had 3 speculums51 and those 3 we had to reserve  for the women in ARV trials, 
we would just do the first 3 women that would come in.  The biggest problem was that the 3 
speculums were different sizes. There was one tiny one for the younger girls; a medium sized 
one and a ‘monster for the big mamas.52’  But you couldn’t chose which one you would use, 
you would just have to take the first one that was available, so a little girl was getting a 
gigantic speculum and a huge women was getting a tiny one. They were so uncomfortable it 
was hard to watch. You could only imagine that they would never want to get a Pap smear 
again.53   
  
                                                 
49 In the year 2005.  
50 50 “Sister” is a term for nurse in South Africa.   
51 A speculum is the instrument used during a pap smear to widen the opening of the vagina so that the 
cervix is more easily visible.  To sterilize a speculum it must be sent off to a facility that sterilizes medical 
equipment.  
52 This was a direct quote from Dr. Warren. 
53 Paraphrased from Dr. Warren’s words, 23/11/06.  All italicized phrases attributed to individuals 
throughout this work are paraphrases.  I had my pen and paper out during most interviews, but I tried my 
best to get down the overall essence of comments and sometimes did not pick up the exact words of my 
interviewees.  
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In this experience, Dr. Warren brings up several resource shortages that are 
supported by other sources.  Dr. Warren first states that “the lab” could never cope with 
the number of pap smears that the clinic needed to be performing.  The lab she is 
referring to here is the national cytological lab that reports the results of pap smears. In a 
similar vein, the 2004 SAHR lists as one of its major challenges in translating national 
cervical cancer policy into effective service as “the limited capacity of national 
cytological labs54.”  Professor Jordaan, too, emphasized a need for more people to work 
in these labs so that we could “actually cater for a greater number of pap smears,”55 and 
Mags Beksinka claimed that, our system in South Africa is very slow, there are many 
steps along the way in which the system fails. Not only to you have to get someone skilled 
to provide the pap, you have to get someone in a lab to get results. A lot of clinics 
struggle with the next step, if they were to implement the policy it would create a whole 
new list of challenges.  From these statements, it seems as though one of the many 
obstacles preventing effective implementation of the national cervical cancer screening 
policy is the inadequate capacity of the cytological labs to determine the cell 
classification.56  
Another resource problem seems to be an equipment shortage, as described by Dr. 
Warren when she attributed the lack of speculums as a barrier to cervical care.   Data 
from a 2003 baseline survey of STI and HIV services, found that 88.2% of South Africa’s 
public sector facilities contained sterile speculums.  Broken up by province, KZN 
                                                 
54 Smit et al., 2004.  
55 Professor Jordaan, 15/11/06.  
56 It is also important to note that the 2004 SAHR included inadequate infrastructure to transport specimens 
to these labs as another key challenge in translating national cervical cancer screening policy into effective 
service. Smit et al., 2004.  
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registered 80%, the lowest of all nine provinces57.  At first glance it may seem that 80% 
is a relatively high number, and a reasonable person could take this to mean that a good 
proportion of public sector facilities in KZN have the ability to perform pap smears58, but 
Dr. Warren’s experience sheds a bit of light on this statistic. Dr. Warren’s clinic would 
likely have registered as one of the public sector facilities with sterile speculums—as 
there were 3 in the facility, yet it is evident from our discussion that these sterile 
speculums were not sufficient to perform anywhere near the amount of pap smears 
necessary to effectively implement the cervical cancer policy.  A much better indicator 
would be statistic on how many pap smears are done in public sector facilities each day, 
but the Department of Health does not have such statistics59.  
 Evidence of an equipment- shortage also came up at Inkosi Albert Luthuli Central 
Hospital, a tertiary and quaternary hospital in the center of Durban.  The gynecologist I 
observed told me that, at Albert Luthuli, he had all the necessary resources to perform the 
number of pap smears and coloposcopies needed per day.  Yet he explained that on 
Fridays, when he worked King Edward VII Hospital, an older tertiary facility that is the 
second largest hospital in South Africa, it was a much different story.  At King Edward 
health care providers often lacked enough speculums and spatulas to perform the needed 
number of pap smears and, according to Dr. G60, often had to resort to recycling 
materials instead of going through the time-consuming process of sterilization61. 
                                                 
57 Smit et al., 2004.  
58 This is assuming that if a clinic has a speculum it would also have a spatula and a glass slide, which 
according to Dr. Jordaan, is very likely.  
59 Smit et al., 2004.  
60 I call this doctor, Dr. G, in order to protect his identity.  
61 Dr. G, 30/11/06.  
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Another resource-gap delineated by many of the relevant stakeholders I spoke 
with was the lack of trained human capacity to implement the cervical screening 
program.  Dr. Amo Jordaan explained that you would quite literally need to have a new 
hired person working for 24 hours a day doing pap smear after pap smear in each clinic 
to get anywhere near the amount that should be getting done.  He also emphasized that 
trained nurses have a high turnover rate, usually staying in clinics for about 5 years and 
then going into “the private sector or Saudi Arabia where they get paid more.” 62 Mags 
Beksinksa, director the of the Durban office of the Reproductive Health and HIV 
Research Unit (RHRU), explained one of the obstacles to screening she saw was that in 
many of the Antiretroviral (ARV) clinics she attended63, there were no “free hands” 
available to provide pap smears64.  And the 2004 SAHR listed “limited number of trained 
service providers in the public sector” as one of the key challenges in implementing the 
national cervical screening policy65.   
The evidence delineated above seems to uphold Joel Perry’s claim that “the 
biggest challenge we face with cervical cancer screening today is the readiness of 
primary healthcare services66.”  The above evidence suggests that many of the target 
women may not be appropriately screened because of a resource-shortage in public 
facilities.  
 
2. Overworked, Overstrained Healthcare Providers 
                                                 
62 Dr. Jordaan, 15/11/06.  
63 ARV clinics are clinics designated by the Department of Health to provide ARVs to HIV- positive South 
Africans with CD4 counts under 200.  
64 Beksinska, Mags. Reproductive Health Unit, University of the Witwatersrand, Durban Office. Interview. 
17/11/06.   
65 Smit et al., 2004.  
66 Joel Perry, 27/11/06.  
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 Another key reason for the failure to implement the cervical screening policy 
seems to be the environment in which many public-sector health care providers work. 
Healthcare providers in the public sector seem to be overworked and, consequently, 
exhausted67.   This was seen quite strikingly, in Nyoni68, when Sister Thandanani 
Simelani, Senior Sister at Wangu Clinic, came and spoke to School for International 
Training (SIT) students about her experiences as a healthcare provider. She described 
how she worked with 3 other nurses.  Together, the four Sisters are responsible for the 
primary healthcare of approximately 18,000 people.  They see around 2, 600 patients 
every month! At the end of her work day, it was visibly difficult for Sister Simelani to 
walk across the street to where she was to lecture the SIT students. She mentioned how 
tired she was several times before and after her talk and chose to sit down to lecture, 
citing the reason for her exhaustion “a long day’s work.”69 The Sisters at Wangu have no 
X-ray lab, no doctor to consult and must transport blood to the nearest hospital whenever 
they need it to be checked.70    
Yet the exhausting work environment in public facilities does not seem to be limited 
to the more rural areas.  Walking into Addington Hospital, a 524 bed, 2,200 staffed 
district and regional hospital in South Beach, Durban, I was shaken by the massive 
number of people just waiting to be treated. The hospital lobby was full of approximately 
200 people sitting in worn-out chairs, many staring into space as if they had been there 
for hours.  I asked one man how long he had been waiting, he said he had been in line 
                                                 
67 Duze, Dr. Principle Medical Officer, Stanger Hospital. Lecture, Experience of a Doctor in a Rural Clinic, 
06/11/06. 
68 Nyoni is a rural town, about 90 kilometers north of Durban.  
69 Sister Thandanani Simelani, Senior Sister at Wangu Clininc, Nyoni. Lecture, 13/10/06. 
70 Sister Simelani, 13/10/06. 
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since 6:00 in the morning—the time was 12:30.  When I made my way to the Oncology 
clinic to meet with Dr. Jordaan, I had to wait in the waiting room as he was still seeing 
patients.  I waited for an hour along with about 40 other women.  During the hour I 
observed nurses bringing in several women in and out of the clinic, outwardly trying their 
best to get as many patients through as possible. I noticed a room designated as STAFF 
ONLY, which seemed to be place in which nurses could relax and have some tea or 
coffee.  Yet there was not one healthcare provider resting in that room.  One nurse was 
limping down the hallway as if something was wrong with her leg, but kept calling 
women in from the waiting room and struggled to walk them into another room, where 
she would disappear until ready to call the next women in to be attended to.  I asked the 
older woman next to me who had been there before I came and was still waiting as I was 
leaving, if she had made an appointment at the clinic for that day.  She had.  If most of 
these people--the 40 or so in the Oncology clinic, the hundreds in the lobby and the 
countless others in other wards of the facility-- did in fact make appointments for that 
day, this means that the hospital is deliberately intending to see this many patients per 
day.71  While this is likely a reflection of the great demand for public health facilities and 
the great need for care, it may also be an eye-opening illustration of how much service 
Addington health care workers are expected to provide day after day.  
At Albert Luthuli, some of the healthcare providers I interacted with also seemed to 
be overstrained.  When I entered Dr. Z72’s Oncology consultation room she quickly sat 
                                                 
71It seems very likely that all these people made appointments. I say that this because of an experience I had 
with Ruby Makhathini during the period that I lived in her home. When she told me the night before that 
she was going to wake up at 4 in the morning in order to get to the clinic early to get a “good place in line,” 
I asked her if she had an appointment.  Shocked at such a question, she told me of course she did, but so did 
everyone else and she wanted to be among the first to be seen.  She did not come home until 5 in the 
afternoon.   
72 Dr Z is another doctor from Albert Luthuli.  I call her Dr. Z to protect her identity.  
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down and said to a nurse “Oh I’m just so busy I don’t know where to be. There is a lot to 
do! ”  And when the patient entered the room the doctor turned to her and made a 
comment about how hot it was outside already, even though it was only 10 am.  The 
patient responded that she was cold already, as she had been waiting inside the hospital in 
line to be seen since 5:30 in the morning.73
  Evidence seems to point to this demanding workload of the public sector 
healthcare workers as another potential reason behind the alleged implementation failure 
of the 2000 Cervical Screening Program.  Data obtained throughout my work has led 
support to the idea that the stressful work environment experienced by public healthcare 
workers often causes i) pap smears to plummet to the bottom of healthcare worker’s 
priorities ii) a negative health care worker attitude toward patients that discourages them 
to come back to clinics in general or if screened to request a smear in the future and iii) a 
cervical cancer screening information-dissemination failure from healthcare provider to 
client, which may lead to inadequate uptake of screening by the patient.   
i. Pap smears as a low priority 
 
“When you have 50-60 very sick patients waiting in line outside, who cares about pap 
smears?”- Dr. Paula Warren74
 
Though pap smears seem to fit directly within South Africa’s 1994 decision to 
focus on primary rather than curative healthcare75, it appears as though a large majority 
                                                 
73 Inkosi Albert Luthuli Central Hospital, Observation. 30/11/06.  
74 Dr. Paula Warren, 23/11/06.  
75 As they are a way to prevent cervical cancer before it becomes invasive and must be cured.  
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of primary care facilities are still forced to focus on curative care76.  As patients often 
present at late stages of disease, healthcare providers are compelled to tend to those most 
in need at the clinics, placing routine primary services such as pap smears on hold 77.  
“Doctors and nurses are too busy,” explained Mags Beksinska when responding to a 
question about how often clinics provide routine pap smears, “if there is a specific reason 
for it they might screen, but there is no routine program going on like you must have one 
[a pap smear] every few years78.”  Dr. Jordaan agreed. When asked if he believes that 
patients are routinely screened for cervical cancer in the public sector, he responded, No, 
nurses are much too busy, they see 100s of patients a day, they won’t perform paps 
regularly, they are too busy processing very sick patients.  And an experience that Dr. 
Warren relayed to me underscored the demanding conditions of some public sector 
workers, and where that puts cervical cancer screening on the list of priorities for many of 
these providers.  
 
There was one night in which I and the other community service year doctor were working 
and we had to do an emergency c- section.  I had already done hundreds of c-sections, but 
none quite this challenging.  Just as we were to begin, the generator completely broke and we 
had no electricity and couldn’t see at all.  We were so nervous and started praying, thinking 
that this woman and her baby were going to die.  We called in the cleaning lady and had her 
hold a lantern over us and began to work.  When the baby came out, she needed emergency 
surgery and the mother was loosing blood very fast.  The other doctor began to take care of 
the mother and I was working on the baby but I couldn’t see a thing so I cut a very crooked 
incision in her artery.  Then the mother needed both of our care so I ran to her and the 
                                                 
76 Smit et al., 2004.  
77 Wellensiek et al, 2002.  
78 Mags Beksikska, 17/11/06.  
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cleaning lady held the artery of the baby closed with a clamp.  After the mother was 
recovering, I went back to the baby and managed to stitch her up in the dark, also crookedly, 
and she too, miraculously, survived.  And experiences like this one were not rare there; we 
dealt with emergencies every day. It was so stressful. Do you see why pap smears are not one 
the top of everyone’s list of things to do? 
 
Dr. Warren’s story illuminates the kind of stress-inducing conditions in which she 
worked during her year in the public sector and where this places pap smears on those 
who work in such condition’s to-do lists.  It seems, based on the above evidence, that 
many women are not getting pap-smears in public sector facilities throughout KZN partly 
because the system is so overstretched with sick patients needing more immediate, 
curative care. In such circumstances, the routine cervical screening required by the 
screening program is simply not a principal concern. 
 
     ii. Negative Attitudes of Healthcare Providers towards Patients  
 
“Nurses generally seem to be overworked and, consequently, exhausted. It is no wonder 
they are not always smiling.” – Dr. Duze, Principal Medical Officer at Stanger 
Hospital79
 
According to Dr. Duze, another consequence of the highly stressful, demanding 
and “often underappreciated80” work of health care providers is negative attitudes from 
                                                 
79 Dr. Duze, 06/11/06. 
80 Dr. Duze, 06/11/06..  
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some providers—particularly nurses-- towards their patients81.  Throughout my 
experience living and studying in KZN, I have found widespread evidence of what Dr. 
Duze calls the “nurse-attitude problem82.”  Epidemiologist Mark Colvin in his lecture to 
the SIT students stated that the attitudes of nurses have been a major issue within the 
public health system in KZN83.  In January of 2006, researchers at the Gender AIDS 
Forum (GAF), an activist Durban-based NGO, dove into the issue of nurse-attitudes in 
their study Things are so wrong out there”: The experiences of women living with HIV & 
AIDS in accessing sexual and reproductive health & rights in KwaZulu Natal, South 
Africa: A study with women living with HIV and AIDS.  The researchers at GAF 
explained that the intent of the paper was to highlight women’s difficulties in accessing 
their reproductive and sexual rights within the public health care sector.  The GAF 
researchers found that the “behavior of healthcare workers towards clients often 
undermining, rude and dismissive84.” Some of they what they uncovered was shocking.   
One patient studied said, if you are sick they shout at you and say that you are 
pretending.  They tell you that you are not the only patient who is sick in the clinic ‘so 
keep quiet and stop making noise’.  Another women reported verbal abuse by a health 
care worker in a clinic where she went for treatment, how are you feeling today—you 
look like granny.   
                                                 
81 Dr. Duze, 06/11/06. A possible explanation to why nurses seem to have more negative attitudes than 
doctors is because, according to Dr. Duze, nurses often work longer hours and see more patients than 
doctors in a day.  Furthermore, nurses get less money and are often less appreciated for their work. 
82 Dr. Duze, 06/11/06.  
83 Dr. Colvin, 19/09/06.  
84 Barnabas L., Madlala N., Magwaza T., Maphumulo T., Mcanyana N, Mlambo R, Mpungose, G., Ngidi 
C., Tallis V. & Tolofi, R..“Things are so wrong out there”: The experiences of women living with HIV & 
AIDS in accessing sexual and reproductive health & rights in KwaZulu Natal, South Africa: A study with 
women living with HIV and AIDS.  24, January 2006. 
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While living with Ruby Makhathini, I witnessed another example of a negative 
healthcare provider -toward patient experience85.   When I arrived back to Ruby’s home 
from class one day in September 2006, I noticed she was on the couch holding her hand 
in pain.  I asked her what was wrong and she explained that after waiting in line for 5 
hours at the clinic for her annual checkup, a nurse came to her with a needle, ready to 
take a shot.  Ruby asked the nurse what the shot was for and the nurse replied to her what 
are you a scared? Are you a child?  When Ruby explained to the nurse that she does not 
usually receive shots in her hand and asked why the nurse was about to give her the shot 
in this location the nurse snickered back are you a doctor?  The nurse then jabbed Ruby’s 
hand with the needle.86  Her hand was completely swollen by the afternoon. Ruby then 
had to wake up the next morning again at 4:15 so that she would wait for hours at the 
hospital in order to alleviate the pain in her hand.  That afternoon Ruby told me that the 
doctor at the hospital told her that she must go to the clinic superior and complain about 
the nurse’s actions.  As far as I know, Ruby never did. What is important to note about 
Ruby’s experience is that she did not receive adequate information from the nurse about 
what the nurse was doing to her and was physically punished when she asked to receive 
information regarding the medical procedure about to be performed on her body.   
It is hard to believe that the same off-putting attitudes of healthcare providers 
would miraculously change when it comes to pap smears.  The GAF study found 
evidence that these negative healthcare worker attitudes had an affect on cervical cancer 
screening specifically.  You do not get comfortable when you are having a pap smear.  
                                                 
85 I lived with Ruby Makhathini from the period of 9/9/06 to 4/10/06. She is a 62-year old, Zulu woman 
living in a government subsidized home in Cato Manor, Durban, South Africa.  She attends only public 
health sector facilities.  
86 As I was not at the clinic with Ruby, all the information presented about this experience was relayed to 
me by Ruby that afternoon.  I did, however, witness the swelling of her hand when I returned from class.  
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One woman reported. The nurse performed a pap smear on me in front of another sister, 
after me telling the sister that I don’t want the other sister to stay.  Another woman 
described how one nurse insisted on watching while the pap smear was done to a woman 
and as the woman left the nurse made a joke out of it.   
This provider-attitude problem seems to impinge significantly on clinic 
attendance in general87.  Of course, if a woman is avoiding the clinic system, it is highly 
unlikely she will be getting screened.  And for those who are screened, such attitudes 
potentially discourage woman to come back for referrals or to uptake screening services 
again in the future. As GAF researchers conclude “because of [nurse-attitudes], women 
often avoid attending health care centers until they are desperate, so remain sick at 
home.”88  
Thus we see that the nurse attitude-problem could potentially be one reason why 
so many South African women have not been screened for cervical cancer and tend to 
only present at clinics when they already have late stage disease89.90   
 
iii. A Cervical Cancer Screening Information-Dissemination Failure  
 
Pap smears are performed on women without any information given about how or why 
it’s done91- KZN clinic patient’s comment to a GAF researcher  
 
                                                 
87 Barnabas et al., 2006.  
88 Barnabas et al., 2006.  
89 Wellensiek et al, 2002.  
90 Not all sources agreed that there is widespread negative attitude and behavior of nurses. Dr. Warren 
explained to me that, in her experience, the really awful nurses were “in the minority” and that most have 
“so much love, go well beyond their work and are really amazing human beings who work under very 
stressful conditions in a remarkable way.” 23/11/06.  
91 Barnabas et al., 2006.  
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Another possible consequence of the overworked, exhausting working conditions 
of the public sector healthcare workers is that such stress leads to a cervical screening 
information- dissemination failure from provider to patient92. In their 2002 study, 
Wellensiek et al. concluded that general education and specific knowledge concerning 
cervical screening are the most important factors to decide whether a screening policy 
will fail or succeed93. Such a statement was corroborated by a report released by 
Reproductive Health Outlook, citing “poor communication between patients and health 
professionals” to be a major problem in developing countries’ cervical screening uptake 
and awareness94.  Several studies have demonstrated that the more information a woman 
knows about cervical cancer, the more likely she is to uptake screening services95.  And 
where is it that  most women get their health-related information?  Their healthcare 
providers.96
I discovered a shocking example of a blatant healthcare provider information 
dissemination failure at Albert Luthuli.  A middle-aged white woman came into the 
consultation room and sat down across from Dr Z. 97   The doctor began reading off her 
medical chart to her in an uninterested, monotone voice.  Yet what she was telling the 
woman was far from banal.  Using esoteric terms that the woman was unlikely to 
understand, she was attempting to inform the patient of a cancer diagnosis.  The patient 
then interrupted the doctor and began saying that “the black and blue was fading on her 
                                                 
92 This alleged information-dissemination failure may not only be a consequence of overstrained working 
environments.  It could also be a result of a lack of knowledge specific to cervical cancer on the part of the 
healthcare provider, a health care provider feeling of superiority over the patient or many other factors.  
93 Wellensiek et al., 2002.  
94 Cervical Cancer Prevention: Key Issues.  Reproductive Health Outlook. (http://www.rho.org). 
18/10/2006. 
95 Wellensiek et al., 2002.  
96 Dr G., 30/11/06.  
97 I will not use this patient’s name or the doctor’s name in order to protect their identities.   
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stomach” and asked the doctor, “what did they do to me in the operation?”  The doctor 
responded that they removed her left and right ovaries, her uterus and her fallopian tubes. 
To my amazement the woman then asked, “why?”  And the doctor responded, “because 
you had cancer, and now you must go to see if it has spread.”  The woman was silent. 
This was the first time the patient found out that she had had her ovaries, uterus and 
fallopian tubes removed.  And it was after the operation. It was also the first she had ever 
heard she had cancer and that it might have spread.  It seems that no one before this 
doctor had properly explained her condition. 98  
This story would likely come as little surprise to Wellensiek et al., who found that 
“health care workers in Durban often do not communicate adequately with patients.”  
While the problem seems to affect many aspects of health care, Wellensiek et al.’s work 
found evidence that was specific to cervical cancer. They discovered that while 27.3% of 
patients reported having had a Pap test, another 9.4% realized they had one in the past 
only after a speculum, a spatula and a glass slide were used for the purpose of 
demonstrating a Pap smear.  Most of these women did not know the name and purpose of 
the test.99  The GAF researchers also spoke to women who backed up the cervical cancer 
information-dissemination failure claim.  One woman said that pap smears are performed 
on women without any information given about how or why it’s done.100  Dr. Jordaan, 
too, said he would attribute part of the cervical cancer screening uptake problem to 
“slackness on the part of the medical profession to advocate strongly to patients about 
                                                 
98 That this was the first time anyone had told the woman of her operation and cancer was confirmed by the 
doctor. Inkosi Albert Luthuli Hospital, Observation. 30/11/06.  
99 Wellensiek et al., 2002.  
100 Barnabas et al., 2006.  
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cervical cancer101.”  And CANSA’s Joel Perry agreed, directly stating that “there is a 
failure in communicating this [cervical cancer] health information to women.”   
At Albert Luthuli, Dr. G described how several of his patients were misinformed 
at their primary clinics before they were referred to him.  He said that many patients with 
preinvasive lesions were told by their previous health care providers that the problem was 
a ‘sore’ in their womb.  Women, he explained, do not take this information very seriously 
and “its possible that many do nothing about it.” At other times, he said, the providers tell 
the patients that they have full-blown cancer, when in reality they only have preinvasive 
lesions that will not develop into cancer if treated.102
Studies have shown that “when people don’t know about pap smears, people 
don’t get screened103” If many woman are not obtaining appropriate and sufficient 
information from their healthcare providers and such information has been closely linked 
to uptake of cervical screening programs, the 2000 cervical screening program may be 
partly failing because some healthcare providers are not disseminating information about 
cervical cancer to their patients.   
 
3. Lack of Public Education on the Value and Purpose of Cervical Screening  
 
“We never read or hear about cervical cancer screenings anymore”—Dr. Jordaan104
 
                                                 
101 Dr. Jordaan, 15/11/06.  
102 Dr. G, 31/11/06.  
103 Dr. G, 30/11/06. This is an exact quote from Dr. G. It is corroborated in substance by Wellensiek et al., 
2002.  
104 Dr. Jordaan, 15/11/06.  
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As detailed above it seems that implementation is failing partly because patients are 
not getting cervical cancer information.  We have seen how there seems to be a failure of 
information specific to cervical cancer disseminated to patients from their providers.  Yet 
there are other, critical places in which a woman could be accessing cervical screening 
information as she goes about her daily life.  Here too is a possible reason for why the 
program is failing in implementation, as there is evidence of a scarcity of information 
about cervical cancer in the public sphere.  
 In 1998 the South African Institute of Medical Research organized infrastructure 
for mass screening in Soweto.  The program had the resources available so that 90,000 
women could get pap smears annually—the necessary screening infrastructure was there.  
Yet the program was deemed largely unsuccessful, as most women did not come to get 
screened.  As the main reason for this failure the authors cited a “lack of planned 
population education and motivation program” to mobilize women to come get pap 
smears.105  In another 2004 study, researchers found that 72% of South African public 
sector facilities that offered cervical screening services did not advertise them106.  
Consequently, many women likely have no idea pap smears are available at their local 
clinics.  
Many of my sources would not be surprised by the Soweto Projects failure or the lack 
of pap smear advertising carried out by facilities as they deem the lack of cervical cancer 
education and information to the public at large as a significant reason why the cervical 
screening program is failing to promote screening uptake. In the 2004 SAHR section 
about cervical cancer, the authors cited a “paucity of information, education and 
                                                 
105 Cervical Cancer Prevention, RHO, 18/10/2006. 
106 Smit et al., 2004. 
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communication material regarding the importance of screening and implications of 
normal cytology,” as another one of the key challenges in translating the national policy 
into effective service107.  The Review recommended widespread dissemination of 
information pertaining to cervical cancer to communities in order to increase uptake.  Dr. 
Roberts asserted that one of the biggest problems in cervical cancer screening uptake is 
that women are not educated at all about cervical cancer108.  Similarly, Dr. Warren 
stressed that one problem was that “[cervical cancer screening] is not advertised in our 
culture at all109.” When I asked Dr. Jordaan what he thought some of the major 
challenges were in the uptake of the cervical screening program, he explained to me that 
fifteen or twenty years ago there were big publicity campaigns about cervical cancer 
screening. It was in the newspaper, it was on the radio, in the clinics.   But you never 
read or hear about cervical screening anymore110.  
If there are cervical cancer awareness efforts, they did not seem to be getting through 
to Ruby111.  When, I went to visit Ruby in November, I casually asked her if she had ever 
had a pap smear- with emphasis on the term.  She looked at me as though I was speaking 
a different language—clearly unsure of the meaning of the term pap smear.  I changed 
course and asked Ruby if she had had cervical cancer screening and she began to talk 
about her breast and what I soon realized was a mammogram—evidently thinking that I 
had asked her about breast cancer.  Minutes later, she changed the subject to something 
                                                 
107 Smit et al., 2004.  
108 Dr. Roberts,  21/11/06.  
109 Dr. Warren, 23/11/06.  
110 Dr. Jordaan, 15/11/06.  
111 Ruby, 2/11/06.  I went to visit Ruby in her home because it was her birthday. The two of us ate cake and 
drank tea and chatted for about an hour before I brought up the cervical cancer topic.  
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lighter and the conversation was over.  These observations lead me to believe that it is 
unlikely any cervical cancer advocacy or education efforts had ever reached Ruby. 
My limited observations in the clinics and throughout the community are also in line 
with what my sources assert.  When waiting in the Oncology clinics of both Addington 
and Inkosi Albert Luthuli Hospitals, I immediately noticed the many colorful signs on the 
walls.  In Addington there were five posters on the wall and all five advertised breast 
cancer awareness.  At Albert Luthuli there were four posters and several pamphlets on a 
table.  The posters advocated breast pumps, osteoporosis, breast feeding and healthy 
eating during pregnancy.  The pamphlets discussed breast cancer and TB.  In both these 
oncology clinics, there was not one visible poster or pamphlet in which a waiting woman 
could learn about cervical cancer—the leading cause of cancer deaths in South African 
women.112 Furthermore, September 2006 was deemed Cervical Cancer Awareness month 
by the Department of Health.  During this month, I lived in Cato Manor, a neighborhood 
in which the great majority of people use public sector facilities.  In this time I walked 
throughout the neighborhood with my homestay brother113, went to the supermarket with 
a relative, visited the Cato Manor Community Center, and explored Durban.  Yet I did 
not see, read, or hear anything about cervical cancer at all.  
 As Joel Perry explained, “there is a challenge to health and social organizations as 
a whole, to provide essential information to the public at large, in this case women in 
particular, to enable them to take charge of their health114.” As such, the apparent lack of 
cervical cancer education and awareness efforts in South Africa seem to be significantly 
                                                 
112 Addington Hospital and Inkosi Albert Luthuli Central Hospital. Observation. 15/11/06 and 30/11/06 
respectively.   
113 My homestay brother is Bhuwa, Ruby’s 15 year old grandson who I shared a home with in Cato Manor.  
114 Joel Perry, 27/11/06.  
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undermining any efforts to strategically implement the 2000 Cervical Cancer Screening 
Program.  
 
PART TWO: A Problem of Context 
 
Above I have discussed in detail possible explanations for why the 2000 National 
Guideline on Cervical Screening has not been comprehensively implemented in 
KwaZulu- Natal.  I have described evidence that there is a resource-deficiency in some 
facilities of the public sector, detailed possible consequences of an overstrained health 
work force and provided evidence that the public-at- large is not receiving sufficient 
education about cervical screening.  In this next part of my paper, I first describe the 
apparent rationale behind the 2000 Cervical Cancer Screening Program.  I then argue that 
based on evidence I have come across, even if the screening policy is sufficiently and 
comprehensively implemented, cervical cancer will likely still be a significant problem in 
today’s South Africa in general and KZN in particular because of the high prevalence of 
HIV. This is because HIV has been shown to 1) decrease the age at which women have 
cervical cancer and 2) decrease the interval of time from dysplasia to cancer and 3) 
increase the likelihood of false-negative results of pap smears.    
 
The Rationale behind the Cervical Screening Program  
 The 2000 National Guideline on Cervical Screening Program is largely based a 
1986 report by the International Agency for Research on Cancer (IARC), a department of 
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the WHO115.  The policy guidelines are likely appropriate and effective for many low-
resource settings throughout the world because of the nature of cervical cancer 
progression.  The peak of HPV infection generally occurs between the ages of 16 and 20 
years. Yet importantly, HPV infection resolves spontaneously in almost 90% of infected 
women.  If a country were to screen and treat women when they begin to be sexually 
active, the great majority (80%) of women may show abnormalities, but most (90%) of 
these abnormalities will regress on their own116.  Consequently, such a program would be 
squandering resources, as most women will clear infection and need not be screened and 
treated.  But in some women HPV infection persists and precancerous cervical lesions 
may follow.  If untreated, these lesions may progress to cancer, usually over a period of 
10-20 years. 117  Since high-grade dysplasia peaks at around age 35, but takes an average 
of 10 years to develop into cancer, it is therefore most realistic and effective in settings 
without the resources to repeat screening frequently over a wide age range to target the 
screening to older women (who have higher risk) in longer intervals (it takes around 10 
years to develop cancer) with an emphasis on higher coverage of the targeted 
populations.118   
 The chart below, found in the National Guideline on Cervical Cancer Screening 
Program and based on WHO figures, shows the evidence the Department used when 
creating the cervical screening policy119.   
 
Number of years between Total smears per Reduction in cumulative incidence of 
                                                 
115 Smit et al., 2004.   
116 Cervical Cancer Prevention, RHO, 18/10/2006 
117 Preparing For the Introduction of HPV Vaccines, March 2006 
118 Sankaranarayanan et al., 2001 
119 National Guideline on Cervical Cancer Screening Programme, 2000. 
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Pap smears lifetime cervical cancer (%) 
1 30 94
3 10 91
5 6 84
10 3 64
 
The Department of Health cited these figures as the reason for proposing their policy of 3 
smears per lifetime, with a 10 year interval between each smear, commencing at no 
earlier than the age of 30 years.  
 Based on the above facts and figures, an implemented 2000 cervical screening 
policy would appear to be an effective strategy to reduce cost, incidence, and mortality of 
cervical cancer.  Yet local data seems to demonstrate otherwise.  Evidence I have found 
suggests that high-grade dysplasia and cervical cancer is a growing problem among 
young South African women.  Dr. Jordaan described how in the past 26 years he has been 
working at Addington and in the last 36 years he has specialized in Oncology, there has 
been a shift to much younger cervical cancer patients, and the shift has been major.  Now 
more and more girls from ages 14 to 35 are coming in and needing treatment120.  
Additionally, the 1998 cervical cancer screening project in Soweto, described above, 
found unexpectedly high rates of dysplasia among young teenagers121.  Dr. Warren too 
noted that “very young girls in South Africa are coming in with cervical cancer122.”  In 
fact, the Minister of Health herself in a speech commemorating Breast, Cervical and 
                                                 
120 Dr. Jordaan, 15/11/06.  
121 Cervical Cancer Prevention. RHO, 18/10/2006. 
122 Dr. Warren, 23/11/06.  
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Prostate Cancer Month stated that researchers have shown that cervical cancer is the most 
common cancer among young South African women aged 15-19 years old123. 
 In the late 80s and early 90s when the policy was being formulated, this may 
indeed have been the most effective cervical screening program124.  Yet, within the 
context of KZN and South Africa today, the above evidence suggests that these WHO 
guidelines may not be the most appropriate and effective model for a National Cervical 
Cancer Screening Program.  There seems to be one main culprit: HIV/AIDS125.   
 
HIV and the Onset of Cervical Cancer 
 
“The mean age of HIV-positive cervical cancer patients is about 13-15 years younger 
than that of their HIV-negative counterparts”- Dr. Manivasan Moodley126
 
 There is emerging evidence that HIV- positive women with invasive cervical 
cancer tend to be much younger than HIV-negative cervical cancer patients127.  A 2006 
study conducted in London matched AIDS and cancer registries and found the average 
age for carcinoma in situ in HIV-infected women and HIV-negative women to be 32.7 
and 47.5 respectively128.  Reproductive Health Outlook asserts on their frequently 
                                                 
123 Speech by Minister Dr. Manto Tshabalala-Msimang at the community event in Mpumalanga to 
commemorate the Breast, Cervical and Prostate Cancer Month.  6/10/06. 
124 Dr. Manivasan Moodley, Department of Gynaecology Oncology, Nelson R. Mandela School of 
Medicine. Interview, 01/12/06.  
125 I must also add that some sources have also suggested that the young sexual debut of African women 
may lead to earlier HPV infection and consequently younger ages of cervical cancer as well.  Smit et al., 
2004.  
126 Dr. Moodley, 1/12/06.  
127 Dr. Moodley, 1/12/06. 
128 Danso, D., Lyons, F., Bradbeer C. Cervical Screening and Management of cervical intraepithelial 
neoplasia in HIV positive women. Int J STD AIDS. 2006 Sep;17(9):579-84. 
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updated website that HIV- positive women with invasive cervical cancer tend to be at 
least 10 years younger than HIV-negative cervical cancer patients129.  And Dr. Jordaan 
cited the reason for the aforementioned shift to younger girls getting cervical cancer was 
increased rates of HIV infection130.   
 Between 2001 and 2006, Dr. Manivasan Moodley and his colleagues at the 
Obstetrics and Gynecology Department at the Nelson R. Mandela School of Medicine did 
research to see if they would find the same link between HIV and cervical cancer in one 
of the world’s highest prevalence areas—KwaZulu-Natal.  What they found was that the 
mean age of the HIV-positive cervical cancer patients that they studied was about 13-15 
years younger than that of HIV-negative patients.  Most of the HIV-positive subjects with 
cervical cancer were in the 30-40 year old age group, whereas the majority of cervical 
cancer subjects who were HIV- negative were in the 50-60 year old age group. 131  There 
thus appears to be a significant association between the age at which women present with 
invasive cervical cancer and their HIV status. 
 
HIV and the Interval of Time from Dysplasia to Cancer 
 
“We have seen time and time again cervical cancer develop within as little as one year in 
our HIV infected patients.”- Dr. G132  
 
                                                 
129 Cervical Cancer Prevention, RHO, 18/10/2006. 
130 Dr. Jordaan, 15/11/06.  
131 Dr. Moodley, 1/12/06. Interestingly, in these studies Dr. Moodley did not find evidence that cervical 
cancer was an AIDS-defining illness in patients with HIV, a link that has been accepted in the United States 
since 1993. 
132 Dr. G, 30/11/06.  
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Well-documented evidence seems to suggest that women infected with HIV 
progress from HPV infection to cervical cancer much more rapidly. The 2006 London 
study described above found that the interval for developing invasive cervical disease is 
indeed shorter, with the average number of years between dysplasia and cancer 15.7 in 
HIV- negative woman and 3.2 in HIV- positive women133.   A 2003 study in Nairobi, 
Kenya found that young women with invasive cervical cancer were more often HIV 
infected and asserted that “these findings suggest an accelerated clinical progression of 
premalignant cervical lesions to invasive cervical cancer in HIV-infected women134.” In 
Durban, a 2002 study also found that locally “HIV alters the natural history of HPV 
infection… with more rapid progression to high grade and invasive lesions135.”   
Furthermore, when talking to Dr. G, he explained that one of major reasons he 
disagreed with the cervical screening policy was the fact that women must wait 10 years 
between smears.  “We have seen time and time again cervical cancer develop within as 
little as one year in our HIV infected patients, he explained, “a 10 year interval between 
tests is much too long136.”  And Dr. Moodley, too, confirmed that the literature has 
consistently shown that there is a more rapid progression from dysplasia to cancer in HIV 
positive women137.  
 
HIV and False-Negative Pap Smears 
 
                                                 
133 Danso et al., 2006.  
134 Gichangi PB, Bwayo J, Estambale B, De Vuyst H, Ojwang S, Rogo K, Abwao H, Temmerman M, 
Impact of HIV infection on invasive cervical cancer in Kenyan women. AIDS. 2003 Sep 5;17(13):1963-8
135 Clark B. & Chetty, R. Postmodern cancer: the role of human immunodeficiency virus in uterine cervical 
cancer. Molecular Pathology,  2002 Feb;55(1):19-24. 
136 Emphasis added. Dr. G, 30/11/06. 
137 Dr. Moodley, 2006. 
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“HIV-infected women were shown to have double the rate of false negative pap smears 
than HIV-negative women”- E Vazquez, 1999.138
 
There is also evidence that HIV- positive women are more likely to receive false-negative 
pap smear results than HIV-negative women.  In a 1999 study, 184 HIV-positive and 
HIV-negative women received a blood sample evaluation, Pap test, coloposcopy, and a 
directed biopsy139. The false-negative rate among the HIV-positive women was found to 
be 37 percent, while the rate among HIV-negative women was 21.4 percent140.  Another 
1999 study found that HIV-infected women were shown to have as high as double the 
rate of false negative pap smears as did HIV-negative women141.  At the 14th 
International AIDS Conference in Barcelona in 2002, researchers reported that HIV- 
positive women are significantly more likely to have false negative pap smears and 
stressed that as such screening at shorter intervals may be warranted to increase the 
likelihood of a correct pap smear result142.  
 
A Department of Health Inconsistency?  
The above evidence that HIV-positive women are getting invasive cervical cancer 
at younger ages, with faster progression from dysplasia to cancer and an increased rate of 
false-negative pap smears is well-documented143.  If HIV- positive women are getting 
                                                 
138 Vazquez E, The danger of using only one pap smear. Posit Aware. 1999 May-Jun;10(3):23.
139 A directed biopsy is when a physician removes small pieces of cervical tissue from areas of the cervix 
where abnormal tissue has been detected.  
140 False-negative Pap test rate high. Newsline People AIDS Coalit N Y. 1999 Apr-May;:31
141 Vazquez, 1999. 
142 Anderson J.., Shah, K., Paramsothy, P., Heilis, C., Jamieson, D., Duen, A. Predictive value of pap smear 
screening in HIV infected and high risk HIV uninfection women. 14th International AIDS Conference, 
Barcelona, Spain. July 7-12, 2002.  
143 Dr. Moodley, 1/12/06. 
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invasive cervical cancer as young as 30, being screened for the first time at that age is 
untenable.  If HIV-positive women are progressing from dysplasia to cancer in rates as 
short as 1-4 years, with a higher chance of false-negative smears, waiting 10 years 
between each smear is just too long. The evidence thus suggests that HIV-positive 
women should be screened for cervical cancer at younger ages, with shorter intervals 
between each smear.144  Yet, the Guidelines for the National Cervical Cancer Screening 
Program states that “to date no association has been found between invasive cancer of the 
cervix and HIV infection145” and therefore does not take the above evidence into account 
in its current cervical screening policy.   
However, there is a noticeable incongruity within the department.  From HIV 
side, the Department does seem to recognize an association between cervical cancer and 
HIV.  In their most recent Guidelines for HIV/AIDS Clinical Care, the Department 
includes carcinoma of the cervix in a section entitled HIV-related malignancies. In 
another section that lists several AIDS-defining illnesses; invasive cervical cancer is 
included on the list. And most significantly, the guidelines emphasizes that “the pap 
smear must be regarded as a routine procedure in woman [HIV] patients and repeated 
annually.”146  Moreover, the link between cervical cancer and HIV also seems to be 
recognized in the Department of Health ARV rollout program.  When a woman comes to 
an ARV clinic and her CD4 count is under 200, she must get a pap smear from the clinic 
before she can receive treatment147. 
                                                 
144 The Center for Disease Control (CDC) in the United States recommends that HIV- positive women 
receive two pap smears at 6 month intervals within the first year of HIV diagnosis, followed by annual pap 
smear tests if those are normal. 
145 National Guideline on Cervical Cancer Screening Programme, 2000. 
146 Emphasis added. HIV/AIDS Clinical Care Guidelines for Adults: HIV/AIDS & STD Directorate, 
Department of Health, 2003.  
147Mags Beksinska, 17/11/06.  
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There thus appears to be a discrepancy within the department regarding the 
association of cervical cancer and HIV.  From the cervical cancer guidelines, the 
department denies any link between HIV/AIDS, but from the more recently updated 
HIV/AIDS guidelines, the link is recognized.  As such, it is likely that some high-risk 
patients are indeed being screened at younger ages (when they present at clinics or ARV 
rollout sites) at more frequent intervals, as the evidence described above suggests is 
necessary.  
  A reasonable person might argue that as long as the department is recognizing and 
treating HIV-positive women differently with regards to cervical cancer, the screening 
guidelines should remain as they are—for older women at longer intervals-- since this has 
been recognized to be the most appropriate and effective  program for a population of 
HIV-negative individuals.  Yet as statistics illustrate, the extent and nature of the 
HIV/AIDS epidemic in KZN makes this sort of approach very troubling.  
 South Africa is approximated to have 10% of the globe’s HIV-infection.  The 
Burden of Disease Research Unit at the Medical Research Council (MRC) estimates that 
out of the nearly 48 million South Africans, 5.4 million are currently HIV-positive. 
Estimates indicate that about four women to everyone one man is infected with HIV for 
individuals aged 15 to 24 years old.  The prevalence for women reaches a peak at ages 
25-29 with 32.5% of the South African population infected with HIV.   KwaZulu-Natal 
has the highest prevalence of HIV infection accounting for approximately 28.7% of all 
South African infections.  It is estimated that around 40% of the antenatal population is 
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HIV- positive and in KZN the highest prevalence of the disease occurs in young women 
aged 20-29.148   
 As can be seen, South Africa has one of the worst HIV/AIDS epidemics in the 
world, KZN has the highest prevalence in South Africa and women between 20 and 29 
have the highest rates in KZN.  And, significantly, there is evidence that many of these 
women do not know their HIV status149.  And those who do know their status must be 
part of the ARV rollout program, and have a CD4 count under 200, to be getting free 
smears. Consequently, though evidence points to the notion that HIV-positive women 
should be getting pap smears at younger ages and at more frequent intervals, it appears 
very unlikely that many of these women are in fact doing so in KZN.    This is because the 
ARV rollout is still very slow, with the majority of people infected with HIV not yet 
accessing this program150.  It is because people with CD4 counts greater than 200 do not 
get pap smears at ARV clinics and must either wait until they turn 30 or until their CD4 
counts drop to below 200 to get their first free smear.151  And lastly, because the 
thousands of positive women under 30 who do not yet know their HIV- status, but are at 
high-risk for cervical cancer, are not being screened at all.152   
If the Department of Health is serious about cervical cancer prevention, it seems 
as though it must update its policy to reflect the South African context described above.  
And my sources appear to agree.  Dr. Jordaan described the policy as “very old 
                                                 
148Dorrington, R., Johnson L., Bradshaw, D., Daniel, T.The Demographic Impact of HIV/AIDS in South 
Africa. National and Provincial Indicators for 2006. Cape Town: Center for Actuarial Research, South 
African Medical Research Council, and Actuarial Society of South Africa.  
149 This may be because of fear of stigmatization and abuse. Dr. Catherine Burns, Department of History at 
the University of KwaZulu-Natal. Lecture, History of Health in South Africa, 26/09/06.  
150 Mags Beksinka, 17/11/06.   
151 Mags Beksinksa, 17/11/06.  
152 Women of course, can pay for pap smears if they are not within the target age group or want more than 
3 smears, but as Dr. G stressed, those who are in the most need for screening are also the ones who cannot 
afford anything but free smears (31/11/06). 
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fashioned153.”  Dr. Warren complained that the policy is completely flawed; women 
definitely need to be screened at younger ages154.  Dr. G told me bluntly that he does not 
agree with government policy at all, mainly because “HIV patients need to be screened 
more frequently.155  And Dr. Moodley asserted that the South African policy is “not 
going to work for HIV positive women” and as such, it is time to “relook at our screening 
policy.”156  It seems that many relevant stakeholders are “fed up”157 with the current 
guidelines and want change.  Perhaps the 2004, SAHR said it best when it stated that 
“due to the prevalence of HIV in South Africa, health researchers and policy makers must 
consider the impact of HIV on the manifestation of cervical cancer and how this would 
relate to the minimum age and intervals between screening158.  
 
 
 
 
 
 
 
 
 
 
                                                 
153 Dr. Jordaan, 15/11/06.  
154 Dr. Warren, 23/11/06.  
155 Dr. G, 30/11/06. 
156 Dr. Moodley, 1/12/06.  It is important to note that the development of policy has often been slow.  As 
Dr. Moodley explained, the process here in Africa is very slow¸ it takes years for the many different 
stakeholders to formulate policy, and often when they finally do the policy is already outdated.
157 Dr G., 30/11/06. 
158 Smit et al., 2004.  
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Conclusions
 
Based on the limited evidence I have gathered through interviews with relevant 
stakeholders, through investigations of relevant documents and through general 
observations from studying and living in KwaZulu-Natal, I have found that it may be 
time for the Department of Heath to reexamine its approach to cervical screening.  The 
evidence I have detailed points to the notion that the current National Guideline of 
Cervical Screening Program does not appear to be comprehensively implemented and 
may not be suitable within the context of the HIV/AIDS epidemic.  I have discussed in 
detail possible reasons for this failure of implementation suggesting that there are 
inadequate resources in the public sector, that overstrained healthcare workers cause pap 
smears to fall low on the list of health priorities, provider attitudes that discourage clinic 
attendance as well as a possible information-dissemination failure from healthcare 
provider to patient.  I have also described evidence suggesting that there is inadequate 
publicity of the cervical screening program to the public- at- large.  
 In addition, I found data that indicates that even if implemented, the cervical 
screening policy may not be suitable within the context of KZN because such a 
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substantial portion of the young female population is infected with HIV.  Studies have 
found that HIV seems to decrease the age at which women have cervical cancer, decrease 
the interval of time from dysplasia to cancer and increase the likelihood of false-negative 
results of pap smears.  Though this evidence suggests that HIV-positive women should be 
getting pap smears at younger ages and at more frequent intervals, it appears very 
unlikely that many of these women are in fact doing so in KZN.    This is because the 
ARV rollout is still very slow, because people with CD4 counts greater than 200 do not 
get pap smears at ARV clinics and must either wait until they turn 30 or until their CD4 
counts drop to below 200 to get their first free smear and because the thousands of 
positive women under 30 who do not yet know their HIV- status are not being screened at 
all.  When a third of women aged 25-29 have HIV; it seems as though a policy ought to 
be formulated that considers this context.159    
   
What I have not said 
 I want to make clear what I have not said throughout this piece.  I have not said 
that the Department of Health policy has grossly missed the mark when it comes to 
cervical cancer. The Republic of South Africa is approaching only its 13 year of 
democracy and has inherited a largely unequal health system in need of major 
overhaul160.  The policies and laws that underwrite reproductive health laws in South 
Africa today are among the most progressive in the world in terms of the recognition they 
                                                 
159 It is important to note that the department of health did not respond to questions about their 2000 
National Guideline on Cervical Cancer Screening Program asked by e-mail and telephone.  
160 Dr Colvin, 19/09/06.  
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give to human rights, including sexual and reproductive rights161.  And when the 
Department of Health formulated its cervical screening program it took into account the 
best available evidence to reduce cervical screening incidence, mortality and cost in low-
resourced settings.   
 Furthermore, competing health needs, such as HIV/AIDS, have justifiably taken 
up much of the Departments attention.  With many women dying of HIV/AIDS even 
before they develop cervical cancer162, it seems vital first and foremost to reduce the 
morbidity and mortality associated with AIDS.  Yet importantly, as more and more 
women are living longer with HIV as the ARV rollout becomes more accessible163, more 
and more women will need to be screened for cervical cancer at shorter intervals and 
younger ages164.   
 
What can be done? 
In her recent165 speech at the Mpumalanga community event to commemorate 
Breast, Cervical and Prostate Cancer Month, Health Minister Tshabalala-Msiman made a 
statement.  After citing that cervical cancer is the leading cancer in South African women 
aged 15-19 and that in 2000, 3,424 South African females died of cervical cancer, she 
said to South African women, “I implore you good people to go for regular screenings so 
that we could help arrest this condition before it is too late.”  If only the Minister 
                                                 
161 Cooper, D., Marroni, C., Orner, P., Moodley, J., Harries, J., Cullingwath L., Hoffman, M. Ten Years of 
Reproductive Health Policy and Status. Reproductive Health Matters 2002, 12 (24): 10-85.  
162 Dr. Roberts, 21/11/06.  
163 Much of the work on the association between HIV and cervical cancer that has been done precedes the 
advent of ARVs. Evidence suggests that the consequences of HIV still negatively impacts the progression 
of cervical cancer in women with higher CD4 counts and consequently that HIV positive women must be 
screened at short intervals.  Still, more research is needed.  Danso et al., 2006.    
164 Danso et al., 2006.  
165 On 6 October, 2006.  
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understood why these “good people” are not able to go for regular screenings.  If only she 
realized that the mere provision of cervical cancer screening does not seem sufficient to 
ensure successful uptake of cervical screening services. Screening has been provided 
through the South African public sector health facilities for many years, yet there has 
been a minimal impact on cervical cancer morbidity and mortality because of the limited 
screening of the population at risk166.  No matter what policy the Department formulates, 
evidence suggests that a comprehensive implementation strategy that is adequately 
planned and takes into account the capacity of the public health system is vital to its 
success167.   
 In addition, the disproportionate number of women infected with HIV in South 
Africa, particularly in KZN, seems to warrant a cervical screening policy that takes into 
account the association of HIV and cervical cancer.  As Dr. Moodley explained, there are 
not many parts of the world where you get such a high HIV prevalence in combination 
with such a high cervical cancer prevalence168.  In this unique context, the WHO 
recommendations may not be the most effective guidelines for cervical screening. And 
thus it may be time to reexamine the country’s Cervical Cancer Screening Program. 
  
 
 
 
 
 
                                                 
166 Smit et al., 2004.  
167 Cooper et al., 2006.  
168 Dr. Moodley, 1/12/06.  
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Epilogue 
 
 The Future: Acetic Acid and the HPV Vaccine 
 
It is vital to mention important new developments that could have a large affect 
on cervical cancer screening, incidence and mortality in the future.  In November of 
2005, researchers at the University of Cape Town found that washing the cervix with 
acetic acid could pick up pre-cancerous lesions as effectively as pap smears169.  This is a 
significant breakthrough because acetic acid—the main ingredient in vinegar-- could 
easily be applied in resource-poor settings as it does not involve expensive laboratory 
procedures.  Studies have also shown that this approach can be implemented by mid-level 
personnel and does not need laboratory services or highly trained staff.  Furthermore, 
screening and treatment, where necessary, can be done at a single visit.  However, the 
                                                 
169 In this procedure, if abnormal cells are present, they show as white lesions after the cervix is washed 
with acetic acid.
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impact of this approach on cervical cancer incidence and mortality still needs to be 
researched.170
 Another exciting new development is the recent introduction of HPV vaccines 
against cervical cancer.  On 8 of June 2006 the United States’ Food and Drug 
Administration (FDA) approved of two vaccines targeting HPV types 16 and 18 which 
are responsible for 70% of cervical cancer cases worldwide.  Results from large studies 
of the HPV vaccines, with about 2-5 years of follow-up, showed almost 100% protection 
against cervical cancer precursor lesions related to the vaccines genotypes.  The vaccines 
are expected to prevent cervical cancer in 70% of HPV-naïve women they are 
administered to.171  Though the price of HPV vaccines for developing countries is still 
not known, the vaccine is currently doing its rounds through South Africa’s Medical 
Control Council172 and according to Dr. Moodley, may be approved within 18 months 
with a negotiated price appropriate to the South African economy173.  These exciting new 
developments should be taken into account when a new cervical screening policy is 
developed. 
 
 
 
 
 
 
                                                 
170 Preparing For the Introduction of HPV Vaccines, March 2006. 
171 Preparing For the Introduction of HPV Vaccines, March 2006. 
172 The MCC is the regulatory body that oversees regulation of medicine in South Africa.  
173 Dr. Moodley, 1/12/06.  
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Limitations of the Study 
 
 All studies have shortcomings and biases.  In this section, I list potential 
limitations and biases in my study with the intention of providing a more holistic 
impression of the work I have done.  
This study was an Independent Study Project (ISP), required by the School for 
International Training (SIT) Study Abroad: Public Health Program.  I was in South 
Africa, collecting the data on an SIT Study Abroad Program which provided the 
composition of my visit by assigning me to specific homestays in specific places and 
providing specific lecturers to address specific Public Health related topics.  It is 
important to note that SIT is a Western-based, liberal-leaning program with ‘first-world’ 
resources and values.   
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The selection of course speakers for the program was an important indicator of what 
aspects of Public Health would be emphasized and how I would finalize my topic choice 
for my ISP.  The collection of speakers was heavily weighted on the researcher and NGO 
employee sector—providing some, but limited information from healthcare providers 
who know about the everyday stresses and challenges of working in the public healthcare 
system and no access to government officials involved in drafting and implementing 
policy.  My study too weighed heavily on the researcher and NGO employee sector.  I 
also interviewed many doctors, but my work falls short when it comes to input from 
nurses, who often do the brunt of the work in the public sector174.  Such researchers and 
NGOs are quite used to being critical of government and perhaps not as able to 
understand and articulate the difficulties of implementation.  The doctors I spoke to too 
may have difficulty understanding the stresses of life as a nurse, as described throughout 
my study.    
I must also mention that my study does not have any input or feedback from the 
South African Department of Health.  I called and e-mailed the department multiple times 
asking questions about the 200 National Guideline on Cervical Cancer Screening 
Program.  I received no response from the department.   
Each source I observed and interviewed likely has predisposed biases because of the 
nature of their race, work and character.  In addition, because they are talking to a 21-
year old, white, American student, informants may have censored their statements.  
Potential predisposed and researcher-influenced biases of each source are described 
below. 
                                                 
174 The reason why my study did not have access to public sector nurses is detailed below.   
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Ruby Makhathini- Ruby is a 62-year old Zulu woman who lives in a government subsidized home in 
Cato Manor, Durban, South Africa.  Its important to note that as an older, arthritis-ridden Zulu women 
living in a township, Ruby may be more prone to complain about the health system because she uses it so 
often and thus has more chances to have negative experiences with the system. Additionally, there are 
several differences between Ruby and myself that could potentially bias the conversation. For one, I am 21, 
the same age as Ruby’s grandson, so Ruby may feel that I am young and say (or refrain from saying) 
certain things because of my age  Yet I am white, and Ruby grew up and lived most of her adult life in 
apartheid South Africa—potentially creating a racial bias in the data.  Furthermore, I am American, a 
country which is often perceived to be able to do something about problems all over the world.  Ruby may 
have detailed certain things to me because she believed that as an American I had the power to do 
something about it.      
Manto Tshabalala-Msimang- I did not meet with the Minister, but instead read Dr. Tshabalala’s 
speech commemorating Breast, Cervical and Prostate Cancer Months.  Because the media and several SIT 
lecturers have condemned the Minister’s work with regard to HIV/AIDS, I may have come with a 
preconceived notion that she is incompetent in her work when reading the words of her speech.   
Mark Colvin- Mark Colvin sees the world from the lens of a white South African academic. He 
likely has never lived the day to day life of an impoverished person.  He is also an epidemiologist, more 
inclined to look at statistics and trends in scientific data than he is to valuing anecdotal evidence. 
Furthermore, Dr. Colvin was speaking to a small classroom of American students and thus may have 
chosen what to speak about or stressed certain things because of the foreign background of his audience, 
possibly with the presumptions that Americans have the money and power to change things in South 
Africa. 
Catherine Burns- Catherine Burns is a white South African historian. She, too, has likely never 
lived the day to day life of an impoverished person and may tend to emphasize historical trends to explain 
problems without focusing on present factors.  Moreover, Catherine Burns was speaking to a small 
classroom of American students and may have chosen what to speak about or stressed certain things 
because of the foreign background of her audience.   
Sister Thandanani Simelani- Significantly, Sister Simelani sees the world through the lens of a 
black South African educated woman.  As an education- empowered nurse it is possible that she fails to 
grasp what an uneducated patient understands and knows about the health system.  She also spoke to us at 
the end of her workday and was noticeably exhausted. In addition, Sister Simelani was lecturing in front of 
a group of 17 American, white students and may have consequently tailored how and what she spoke about 
and stressed because of the background and race of her audience—especially considering that Sister 
Simelani lived most of her adult life in apartheid South Africa. 
Dr. Duze- It is important to note that Dr. Duze is an educated black doctor.  He may feel superior 
to uneducated Africans from impoverished backgrounds and fail to relate to their problems. Furthermore, 
Dr. Duze was answering questions from a group of 17 American students and may have consequently 
stressed certain things in his answers because of the background of his audience. In addition 16/17 of these 
students were white and Dr. Duze lived most of his adult life in apartheid South Africa—potentially 
creating a racial bias in the data.  
Dr. Amo Jordaan—Dr. Amo Jordaan is a white South African who has worked in Oncology 
department at Addington hospital through a period of historical change in South Africa.  It is important to 
note that Dr. Jordaan works in the public sector and has chosen to work mainly in Gynecology.  It is 
possible that he has chosen to remain in the public sector because he is liberal leaning and may believe in 
saving lives of those most in need.  I could also be that the practical day to day work in the public sector 
has corrupted any romantic views of racial and socio-economic equality he may have had.  It is also 
important to acknowledge that Dr. Jordaan spoke to me about the factors behind getting cervical cancer, 
which is a disease of females.  As a white male, Dr. Jordaan has likely never lived in the conditions many 
of his cervical patients have had to live through.  Also noteworthy is that Dr. Jordaan was speaking to me, a 
white, female, American student and may have stressed certain things because my gender, age or foreign 
background, possibly with the presumptions that Americans have the money and power to change things in 
South Africa. 
Mags Beksinska- Mags Beksinska has moved to South Africa in her adult life and has 
Scandinavian roots. As an immigrant to South Africa, she might have less of a grasp for the historical 
changes with regard to reproductive health as someone her age who has lived here their whole life.  She 
also likely has never lived the day to day life of many of the impoverished, ill people she researches and 
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likely does not herself attend public facilities. It is also important to note that Mags Beksinkska was talking 
to a young, American student and may have stressed certain things because my age or foreign background.  
Gender AIDS Forum (GAF)- Because it has liberal, feminist roots, GAF may tend to look at the 
AIDS with a bias toward women’s needs without seeing the epidemic within the context of the larger 
public health sector system.  Moreover, as an NGO, they likely have little experience with the challenges of 
policy implementation. As I searched through their resource room on my own, it is unlikely that there is a 
researcher-influenced bias here.  
Charlie Roberts- As a white South African Doctor in the private sector, Dr. Roberts has likely 
never lived the day to day life of an impoverished person.  In addition, as a private sector physician, he may 
not understand the challenges and stress-inducing conditions of work in the public sector facilities of South 
Africa. It is also important to note that Dr. Roberts was speaking to me about cervical cancer, a disease in 
which he, as a man, may not comprehensively understand. Furthermore, Dr. Roberts was speaking to me, a 
white, female, American student and may have stressed certain things because my gender, age or foreign 
background. 
Paula Warren- Dr. Warren is a young, white doctor currently working in the private sector, who 
worked in the public sector last year.  Because of her young age, Dr. Warren may tend to be more idealistic 
than the other, older doctors I spoke to.  Furthermore, because she chose to leave the public sector, she may 
have certain negative memories of her experiences that potentially could have biased her answers to my 
questions.  I mentioned to Dr. Warren that I was interested in becoming a doctor and she may have 
emphasized certain aspects of her job because she knew I was interested in the field.  Furthermore, Dr. 
Warren may have stressed certain things because of my foreign background. 
Joel Perry- Joel Perry is a white South African who is the Cancer Association of South Africa’s 
(CANSA) Director of Health Programs.  It is important to note that Joel Perry was speaking to me about 
cervical cancer, and as a man, he has no risk for this disease.   Additionally, Joel Perry was speaking to me, 
a white, female, American student and may have stressed certain things because my gender, age or foreign 
background. 
Dr. G.- As a black, male Gynecologist working at the Obstetrics and Gynecology Department of 
the Inkosi Albert Luthuli Hospital in Central Durban, Dr. G likely understands the cultural and social 
background of many of his patients, but as man has no risk for cervical cancer and has therefore never 
experienced the social consequences of contracting this disease. Also, as a highly educated man, he may 
feel superior to uneducated Africans from impoverished backgrounds and fail to relate to their problems 
Furthermore, what Dr. G said to patients may have been biased by my presence in the consultation room.  
Even though he knew his identity would be hidden in my study, he may have said or stressed certain things 
to his patients because of the knowledge he was being observed by a young, white, foreigner.  Also, he 
translated what he said to the patients into English from Zulu, with the understanding that I did not speak 
Zulu.  There could potentially be a language barrier, and it is unlikely that the translation was exact.   
Dr. Z.- Dr. Z is a black, female Oncologist working at Obstetrics and Gynecology Department at 
Inkosi Albert Luthuli Hospital in Central Durban. As an educated women, she may feel superior to 
uneducated Africans from impoverished backgrounds and fail to relate to their problems. Furthermore, 
what Dr. Z said to her patient may have been biased by my presence in the consultation room.  Even though 
she knew her identity would be hidden in my study, she may have said or stressed certain things to her 
patient because of the knowledge she was being observed by a young, white, foreigner.   
Manivasan Moodley-  Dr. Manivasan Moodley is a doctor and researcher at Department of 
Obstetrics and Gynecology, Nelson R. Mandela School of Medicine.  As a highly educated and well-
respected academic, it is unlikely that Dr. Moodley lives the day to day impoverished lives of many of his 
patients.  As my advisor, Dr. Moodley also had influence over who I spoke to and what I included in my 
work.   I also knew that Dr. Moodley would be evaluating my paper, potentially biasing the contents of the 
study.   
  
I must also acknowledge that many, though not all, of my secondary sources are 
academic papers published in International journals.  As most International journals tend 
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to have a Western-bias, there may be such a bias in my secondary sources.  In addition, 
the short list of articles that inform the study is by no means a comprehensive collection 
of the literature written on the topic.  
  Statistics constitute a large component of my study.  As Benjamin Disraeli is so 
often quoted, “there are three kinds of lies:  lies, damn lies, and statistics.”  Of course, it 
is vital to acknowledge the inherent limitations in data collection and analysis and 
therefore stress that all statistics in this paper—whether obtained from primary or 
secondary sources-- should be eyed with caution, keeping in mind the inherent and 
researcher-influenced bias of the source.   
 It is critical to also acknowledge my own personal constructed identity as a white, 
American female who has been getting pap smears annually since the age of 16 and has 
remained healthy.  Such a background may create partiality in my writing for 
innumerable reasons.  My female identity may bias me to sympathize with the health 
needs of South African women, as I noticeably remembered more from lectures about 
women’s health.  As an American, I have also been told that a woman is supposed to get 
a pap smear annually from the time she is sexually active or turns 18.  Because of this 
policy, and my belief in its efficacy of preventing cervical cancer, I may have a tendency 
to be critical of another screening policy that is not my own.  I also must recognize that 
the limited nature of this short research paper means that I do not have enough time to 
cover every side and argument to the issues presented.   
It is also important to note that the study carried out was not the one I originally 
intended to study.  This original project was based on evidence from Wellensiek et al.’s 
paper that a large problem with cervical cancer screening uptake in KZN is a failure of 
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communication from healthcare provider to patient. I intended to jump into this issue, by 
questioning healthcare providers in the public sector about how they perceive, screen and 
disseminate information about cervical cancer screening services within the context of 
the HIV/AIDS epidemic.  I wanted to do this by providing a brief questionnaire to public 
sector healthcare providers.  For the Proposal of the originally intended project proposal 
please see Appendix B.  And to see the Questionnaire, please see Appendix C.  
 The reason why I did not carry out the project of my original intent was because 
of the many roadblocks in order to receive permission to submit my questionnaire to 
healthcare providers.  I submitted by e-mail my Proposal, Ethics Approval and 
Questionnaire to Mr. Timothy Msiza, District Health Manager of KwaZulu-Natal.  He 
said everything needed to be signed and I had to go to each clinic I intended to distribute 
my questionnaire and get their permission ahead of time.  On the other side, these clinics 
said in order to come in, I needed Mr. Msiza’s permission. Because this process was so 
time-consuming, I decided to change my project to an evaluation of the 2000 National 
Guideline on Cervical Cancer Screening Program by talking to relevant stakeholders, 
without submitting the questionnaire.   
 
 
 
 
 
 
 
 60
  
 
 
 
 
 
 
 
 
 
Recommendations for Further Study: 
 
There are many avenues for further study discussed in this piece. Suggestions include: 
 
- Research on the best strategy for implementation of a cervical cancer screening policy 
given the capacity of public health facilities throughout KZN and the rest of South 
Africa. 
 
- Research on how the advent of ARVs may affect the association between HIV and 
cervical cancer.  
 
- Further research on the interval of time from dysplasia to cervical cancer in HIV-
positive patients specific to South Africa.  
 
-Further research on the rate of false-negative pap smear results in HIV-positive patients 
specific to South Africa 
 
-Research on the impact of the acetic acid screening approach on cervical cancer 
incidence and mortality.  
 
-Research on how efficacy and safety of the HPV Vaccines in HIV infected individuals 
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-Research on the most strategic way to introduce the HPV Vaccines within the South 
African context.  
 
-Research on how healthcare providers in Durban, South Africa Perceive, Screen and 
Disseminate Information about Cervical Cancer Screening Services within the Context of 
the HIV/AIDS epidemic (my original intention). 
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Appendix A: Glossary of Terms 
Carcinoma: Cancer that begins in the skin or in tissues that line or cover body organs. For example, carcinoma can 
arise in the breast, colon, liver, lung, prostate, and stomach.  
 
Carcinoma in situ: Cancer that involves only the place in which it began and that has not spread. Carcinoma in situ is 
an early-stage tumor.  
 
Cervical cancer: Cancer of the entrance to the womb (uterus). The cervix is the lower, narrow part of the uterus 
(womb). The uterus, a hollow, pear-shaped organ, is located in a woman’s lower abdomen, between the bladder and the 
rectum. The cervix forms a canal that opens into the vagina, which leads to the outside of the body.  
Regular pelvic exams and Pap testing can detect precancerous changes in the cervix. Precancerous changes in the 
cervix may be treated with cryosurgery, cauterization, or laser surgery. The most common symptom of cancer of the 
cervix is abnormal bleeding. Cancer of the cervix can be diagnosed using a Pap test or other procedures that sample the 
cervix tissue. Cancer of the cervix requires different treatment than cancer that begins in other parts of the uterus. 
Cervix: The cervix is the lower, narrow part of the uterus (womb). The uterus, a hollow, pear-shaped organ, is located 
in a woman’s lower abdomen, between the bladder and the rectum. The cervix forms a canal that opens into the vagina, 
which leads to the outside of the body 
 
Colposcopy : A procedure in which a gynecologist uses a lighted magnifying instrument which is called a colposcope 
to examine the tissues of the vagina and the cervix. 
 
Dysplasia: Abnormal in form. From the Greek dys- (bad, disordered, abnormal) and plassein (to form). For example, 
retinal dysplasia is abnormal formation of the retina during embryonic development. 
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Human papillomavirus: HPV. A family of over 100 viruses including those which cause warts and are transmitted by 
contact. Some types of HPV are associated with tumors of the genital tract including, notably, cancer of the cervix. 
Invasive cervical cancer: Cancer that has spread from the surface of the cervix to tissue deeper in the cervix or to 
other parts of the body.  
Pap Smear: A screening test for cervical cancer based on the examination under the microscope of cells collected from 
the cervix , smeared on a slide and specially stained to reveal premalignant (before cancer) and malignant (cancer) 
changes as well as changes due to noncancerous conditions such as inflammation from infections.  
 
Speculum: An instrument used to widen an opening to look within a passage or a cavity. For example, a speculum may 
be used to widen the opening of the vagina so that the cervix is more easily visible. Other examples include the nasal 
speculum to look up into the nostrils and the ear speculum to look within the ear canal at the ear drum. The term 
“speculum” is the Latin word for mirror. 
 
Squamous cells: Flat cells that look like fish scales. The word “squamous” came from the Latin squama meaning “the 
scale of a fish or serpent.” 
Squamous intraepithelial lesion (SIL): A general term for the abnormal growth of squamous cells on the surface of 
the cervix. The changes in the cells are described as low grade or high grade, depending on how much of the cervix is 
affected and how abnormal the cells are.  
 
 
 
 
 
Appendix B: Original Project: Proposal  
 
 
 
To Smear or Not to Smear?:   
A Snapshot at How Health Care Providers in Durban, South Africa Perceive, 
Screen and Disseminate Information about Cervical Cancer Screening Services 
within the Context of the HIV/AIDS epidemic  
 
 
Although it is a preventable disease that is curable if detected and treated in its early 
stages, cervical cancer remains the leading cause of cancer deaths among South African 
women.  Women attending public sector services are entitled to three free Pap smears in 
their lives, yet the majority of eligible South African women have never had a Pap 
smear175. In the HIV-burdened area of Durban in KwaZulu Natal, South Africa, cervical 
cancer poses an even greater threat as it is considered an AIDS defining illness in women 
affected with HIV176. This project aims to get a snapshot of how different health care 
                                                 
175 CANSA, Cancer Association of South Africa, More services needed to fight cervical cancer 
(www.givengain.com), 29/10/2006. 
176 Cervical Cancer Prevention: Key Issues.  Reproductive Health Outlook. (http://www.rho.org). 
18/10/2006. 
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providers in Durban perceive, screen and disseminate information about cervical cancer 
within the context of the HIV/AIDS epidemic. The study also aims to examine expert 
perceptions of the efficacy of the Republic of South Africa’s cervical cancer screening 
policy. The project will interview public and private healthcare workers as well as 
experts in the field throughout the Durban area.  Interviews will primarily take place at 
public health clinics in the greater Durban area as well as the Nelson R. Mandela School 
of Medicine. 
 
While frequently repeated cytology screening have led to an 80% decline in cervical 
cancer mortality in developed countries, cervical cancer remains an important public 
health problem among adult women in the developing world. Due to more limited health 
care resources, developing countries cannot afford the model of frequently repeated 
screening of a wide age range of women that are used in developed countries.  In such 
resource limited countries, the World Health Organization (WHO) supports the concept 
of reducing the number of smears per women per lifetime in favor of more women in the 
population having fewer smears177.  Yet even despite available screening facilities, the 
incidence of cervical cancer remains high with very few women being screened. And 
though most developing countries have registered either a stable or slowly declining trend 
in cervical cancer incidence, regions in sub-Saharan Africa have registered an increased 
incidence in recent years.178
 
In South Africa, cervical cancer affects 1 in every 41 women179. It is the leading cause of 
cancer deaths in South African women180. And while the Department of Health’s stated 
policy is that South African woman will receive 3 smears per lifetime with a 10 year 
interval between each smear, commencing at no earlier than age 30181, the majority of 
eligible South African women have never been screened for cervical cancer182.   
 
Highly pertinent to South Africa, cervical cancer has been shown to be an important 
AIDS-related disease in women. Studies have shown that there is a higher prevalence of 
HPV infection in HIV positive women and that women with HIV have risk of more 
virulent HPV with more rapid progression from infection to neoplasia.183  Evidence also 
suggests that HIV positive women with invasive cervical cancer are about ten years 
younger than their counterparts who are HIV negative. With 13.3% of South African 
women HIV positive184, and with HIV/AIDS rates highest in KwaZulu-Natal, such 
cervical cancer-AIDS links are highly relevant.  Current WHO screening 
recommendations are to screen HIV positive women every 6 months with a Pap smear 
                                                 
177 National Guideline on Cervical Cancer Screening Programme. Republic of South Africa Department of 
Health, 1999. 
178 Sankaranarayanan et al.  
179 National Guideline on Cervical Cancer Screening Programme, 1999. 
180 Sankaranarayanan et al.  
181 National Guideline on Cervical Cancer Screening Programme, 1999. 
182 CANSA, Cancer Association of South Africa, More services needed to fight cervical cancer 
(www.givengain.com), 29/10/2006. 
183 Cervical Cancer Prevention: Key Issues, 18/10/2006. 
184 Ayesha BM Kharsany PhD, CAPRISA, University of KZN, South Africa , 30/10/2006. Lecture: HIV 
Epidemiology and Prevention 
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and refer for colposcopy any women who has atypia or dysplasia on her Pap smear185.  
Yet the South African Department of Health Cervical Cancer Screening policy still 
asserts that there is no proven link between HIV and invasive cervical cancer186. 
 
Studies have shown that women in developing countries lack information on cervical 
cancer and know little about screening services available to them.  Health care providers 
often have poor technical training in cervical cancer screening/treatment, education and 
counseling.187  A 2002 study in Durban, South Africa that looked at knowledge of 
cervical cancer screening and use of cervical screening facilities of women from various 
socioeconomic backgrounds concluded that general education and specific knowledge 
concerning cervical screening are the most important factors to decide whether a 
screening policy will fail or succeed.  The authors found evidence that “health care 
workers in Durban often do not communicate adequately with patients.”  In support of 
this claim was the finding that while 27.3% of patients reported having had a Pap test, 
another 9.4% realized they had one in the past only after a Cusco speculum, a spatula and 
a glass slide were used for the purpose of demonstrating a Pap smear.  Most of these 
women did not know the name and purpose of the test.  Wellensiek et al. conclude that 
this was due to failure on the part of the healthcare giver to disseminate information to 
the patient regarding the reason and value of cervical screening.188 Research on how 
different health care providers in Durban perceive, screen and disseminate information 
about cervical cancer within the context of the HIV/AIDS epidemic are crucial to the 
success of cervical cancer prevention programs.  Such is the basis for my study. 
 
By the end of the project I will have a limited snapshot of the perceptions that a small 
sector of Durban healthcare workers have on cervical cancer screenings and a greater 
understanding of some experts opinion on the Department of Health’s cervical cancer 
screening policy.  I will also be able to observe the differences in health care worker 
knowledge, procedures and counseling to HIV positive versus HIV negative clients. 
 
The majority of the data gathering will take place from the period of 13 November to 1 
December, 2006.  Some of the interviews will take place at  public clinics with nurses 
who are in the facility on the given day that I provide a questionnaire to.  I will also 
interview private sector healthcare providers.  The interviews with academics will take 
place over the phone if a meeting cannot be set up or if the academic works in a different 
part of the country.   
 
The interviews will be in the form of interviews/ guided conversations for academics 189 
and questionnaires for health care providers.   
 
Academics: The interviews with the academics will be more formal question and answer 
sessions as well as guided conversations.  The overall goal is to understand the research 
                                                 
185 Cervical Cancer Prevention: Key Issues, 18/10/2006. 
186 National Guideline on Cervical Cancer Screening Programme, 1999. 
187 CANSA, 29/10/2006. 
188 Wellensiek et al, 2002. 
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to date on cervical cancer perceptions, awareness and risk factors, its link to HIV/AIDS 
and to gain insight into the current challenges in the field.   
 
Nurses/Doctors: The interviews with the nurses/doctors will be in the form of 
questionnaires.  The questionnaire is attached below.  
   
The budget for the project will be broken up as follows:  
Accommodation/day: R50 
Food/day: R50 
Total Interview money: R15 x 15 people = R 225 
Transportation/day: R50 
Printing/Binding: R100(?) 
 
I will be guided by Dr. Manivasan Moodley, Department of Gynaecology Oncology, 
Nelson R. Mandela School of Medicine.  He can be reached at moodleym29@ukzn.ac.za 
or at 0824627518.  
 
 
 
 
 
 
Appendix C: Original Questionnaire 
 
Cervical Cancer Screening Questionnaire 
 
 
1. At what age do you generally give your patients their first pap test? 
 
 
 
 
 
2. What factors contribute to your decision to give a patient a pap test? 
 
 
 
 
 
3. What do you tell a patient before and after you give them a pap test? 
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4. What do you tell a patient who is HIV positive about how often she should come for 
cervical cancer screening? 
 
 
 
 
 
5. What proportion of women over the age of 40 visiting your clinic have never had a pap 
smear? (circle one) 
 
All have had- Most have had- Half have had- Most haven’t had- Virtually none have had 
 
 
 
 
6. What do you see as the biggest challenge with cervical cancer screening in South 
Africa today? 
 
 
 
 
 
 
Appendix D: National Guideline of Cervical Cancer Screening Programme 
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